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 Wound healing and revascularization of tissues at sites of injury are fundamental 
problems in the field of regenerative medicine. One promising approach to supporting 
vascularization is the use of fibrin polymers, the natural blood clotting protein, as an 
injectable biomaterial construct. Current fibrin matrices/sealants for wound healing 
applications use high concentrations of fibrinogen and thrombin, forming a dense matrix 
to facilitate stable clot formation. However, this limits the ability for endogenous cells to 
infiltrate the wound site for adequate tissue repair. The overall goal of this work is to 
design materials that are mechanically robust for ease of handling and clot stability, but 
allow for increased cell infiltration and tissue regeneration by modifying the fibrin 
network ultrastructure. This is achieved using colloidal assemblies of ultra low cross-
linked poly(N-isopropylacrylamide) pNIPAm microgels (microgels), which we have 
shown can alter network architecture and mechanics. We hypothesized that by modifying 
microscale network structure we would enhance infiltrating cell motility, endogenous cell 
recruitment and angiogenesis, and tissue regeneration. Ultimately, it was shown that 
microgels enabled enhanced cell motility and infiltration in vitro, and in-growth of small 
diameter vessels in vivo. While, enabling larger vessel vascularization and multicellular 
processes involving collective cell migration still remain to be realized, this novel system 
represents a new method of modifying dense biomaterial systems for enhanced 





CHAPTER 1  INTRODUCTION 
1.1 Specific Aims 
 A major challenge in tissue engineering and regenerative medicine is the ability to 
design materials with robust mechanical properties while simultaneously being 
permissive to cell invasion. This is difficult because the mesh size of a network is directly 
linked to the material’s elastic modulus, with small mesh sizes being inhibitory to cell 
motility. Many tissue engineering approaches utilize natural protein-based polymer 
systems due to their enhanced endogenous bioactivity and potential for seamless 
integration with the host tissue. However, most natural biopolymers form weak hydrogels 
that do not fully match the mechanical properties of the target tissues making them 
difficult to apply in practice [1]. Thus, in order to strengthen these networks, higher 
concentrations of protein are used [2-4], exogenous crosslinkers are added [5], or 
synthetic polymers are incorporated into the matrices to form more mechanically robust 
networks [6, 7]. However, these approaches imply a smaller network mesh size, which 
physically inhibit cellular processes such as spreading and migration – prerequisites for 
cell infiltration and biomaterial integration. This establishes a significant discord in 
biomaterials design where one must either choose desirable tissue mechanical matching 
or cell infiltration and tissue ingrowth, while both together are difficult to achieve.  
 Fibrin is an attractive native protein used in tissue engineering and tissue sealant 
applications, but in order to perform as a sealant, it must be used at supraphysiological 
concentrations for stable clot formation. When used at these concentrations, cell 
infiltration is greatly reduced, hindering tissue remodeling and regeneration and 
ultimately leading to scar tissue formation. As opposed to engineering growth factor 
 2 
delivery [8] or release of recombinant proteins [9], and inspired by the space-filling 
functions of high molecular weight proteoglycans within natural ECMs [10, 11], here we 
combined high volume fraction colloidal assemblies of ultra-low crosslinked (ULC) 
microgels with the natural extracellular matrix protein fibrin to make unique composite 
materials to allow for structural modifications to the polymer matrix to provide 
therapeutic benefit. Instead of remaining homogenously dispersed, microgels cluster 
within fibrin forming interconnected networks with properties similar to that of well-
packed semi-fluid domains. We investigated the mechanisms of formation of these 
composite materials, and found them to assemble into interconnected networks within the 
composite, which is key to the observed enhanced cell and tissue phenotype. 
Additionally, the mechanical properties of the composite gels were indistinguishable 
from fibrin alone. We achieved these structures dynamically, via polymerization 
dynamics of the bulk polymer, or via depletion interactions and subsequent gelation.  
 Thus this dissertation focuses on two main objectives: 1) characterizing fibrin-
microgel hybrid constructs and their ability to enhance cell motility and infiltration, and 
2) understanding the fundamental biophysics of the formation of composite biomaterial-
colloidal assembly hybrids. The overall hypothesis of this work was that by modifying 
the microscale network structure we would enhance infiltrating cell motility, endogenous 
cell recruitment and angiogenesis, and ultimately tissue regeneration. This was 
accomplished through the following specific aims:  
Aim 1: Characterization of ultra-low crosslinked microgels and fibrin-microgel 
hybrid constructs. The generation of composite fibrin-microgel constructs was explored. 
The hypothesis of this aim was that microgels would form interconnected structures 
 3 
within fibrin gels and that the mechanical properties of the composite would be 
maintained and comparable to the fibrin alone gel. The objective of this aim was 
characterize the system, using light scattering and viscometry1, and study the effects of 
adding various concentrations of microgels to high concentration fibrin gels, through 
rheology, confocal microscopy, and image processing. 
  
Aim 2:  Determination of the effects of fibrin-microgel hybrid constructs on cellular 
phenotype, and investigation of the mechanism of microgel network formation in 
fibrin and other materials. This aim focuses on understanding how the composite 
materials are formed and the effect of these constructs on cellular phenotype when 
compared to fibrin only controls. The hypothesis of this aim was that the addition of 
microgels would allow for increased cell spreading, motility, and infiltration. This was 
assessed through quantitation of cell morphological outputs and live-cell imaging. 
Additionally, the hypothesis of the mechanistic sub-aim was that the size and shape of 
microgel networks within fibrin would be dictated by the polymerization rate of fibrin. 
This was tested through confocal imaging, image processing, and rheology. 
 
Aim 3: Determination of the potential of fibrin-microgel hybrid constructs to 
enhance cell infiltration using in vivo systems. The angiogenic potential of these hybrid 
constructs was measured and quantified. The hypothesis for this aim was that the 
presence of microgels would enhance angiogenesis and vascularization due to the ability 
of microgels to enhance migration. A subcutaneous implant rodent model and several in 
vitro angiogenesis assays were tested to measure the regenerative effects of microgels. 
                                                
1 Portions adapted from Bachman et al. Ultrasoft, highly deformable microgels, Soft Matter, 11 (2015) 
2018-2028. Adapted from with permission by The Royal Society of Chemistry. 
 4 
 Therefore, in situ assembly of these unique structures represents a simple, 
straightforward method for generating robust tissue integration and in growth of 
functional vascularization within dense polymer matrices. 
1.2 Significance of Research 
There is a great need to develop materials that aid in regeneration and 
subsequently promote the formation of a stable vascular network for long-term tissue 
survival. The field of tissue engineering and regenerative medicine is vast with much 
research being focused on designing elegant strategies to recapitulate the native ECM 
using engineered synthetic systems [12]. While these achieve some of the desired 
outputs, significant barriers and issues related to clinical feasibility still remain from 
these materials being translated to the clinic [13, 14]. Additionally, the use of growth 
factors and other proteins in synthetic systems significantly increases the cost, decreases 
the shelf life, and in some cases makes them cost-prohibitive in the healthcare system 
today unless they demonstrate extraordinary benefits.  
Thus, the simplicity of the system described herein offers many advantages 
compared to more complex potentially over-engineered parallels. These include: the use 
of a natural polymer with inherent bioactivity, in situ polymerization of the composite to 
allow for filling of defects and shape matching, and minimal compositional changes to 
current FDA-approved products (fibrin sealants). We propose a simple strategy of 
forming composite materials through the mixing and subsequent gelation of fibrin-
microgel constructs. These materials are also translatable and could be incorporated into 
fibrin sealant products or in other systems where the injury repair process and 
angiogenesis are compromised [15, 16]. 
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The innovation of this work is that it provides the proof of principal concept that 
polymeric soft materials can generate novel functions relevant to biology (increasing cell-
viewed porosity of a dense fibrin matrix) to both modulate the mechanics and 
ultrastructure of an environment without obstructing cellular processes, but instead 
accelerating them. This represents the first description of a porogen-like material being 
generated without the removal of the porogen itself. While microparticles have been 
incorporated into fibrin previously in order to deliver drugs [17-19] or other factors or 
mechanically reinforce the network [20, 21], there is no evidence of investigators using 
volume fractions of colloidal microparticles as high as explored in this work. 
Additionally, based on the physics of phase behavior of certain particle types [22, 23], it 
may be impossible for certain types of microparticles to be used at these high of 
concentrations, making this phenomena potentially unique to deformable soft materials. 
The idea of generating tunnels of deformable and yet water swollen colloidal assemblies 
for cells to explore within biomaterials is a fundamentally new concept in tissue 
engineering design. Others have used the softness of microgels in order to achieve 
desirable cell-mimicking properties [24], but particle softness has not been explored in 
the context of cell migration in composite networks. Therefore, the ins and outs of the 
system will be explored and explained in detail in the following pages.  
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CHAPTER 2  LITERATURE REVIEW 
2.1 Biomaterials in tissue engineering 
2.1.1 The extracellular matrix2 
 The essential non-cellular component of all tissues is the ECM, the protein 
scaffold and microenvironment in which cells reside [25]. A schematic representation of 
the ECM is presented in Figure 1. The protein composition and structure of the ECM can 
influence cell adhesion and signaling, as cells bind to specific ligand sites on ECM 
proteins via cell surface receptors, including integrins and proteoglycans [26]. Cell-ECM 
interactions are complex and dynamic in nature and can dictate cellular phenotype, 
influencing cell survival, proliferation, migration, and differentiation. Various ECM 
proteins also bind and sequester growth factors, which can lead to spatial and temporal 
control of the dynamics of cellular processes [27]. Additionally, the ECM can determine 
the mechanical properties of each organ through its compressive modulus, elasticity, and 
water retention, which can play a protective role in tissues to maintain homeostasis.  
There are several canonical ECM proteins that are prevalent throughout many 
tissues in the body, each with their own complexities. Most tissues are heterogeneous 
mixtures of various proteins including collagens, laminins, and proteoglycans among 
others. A primary function of ECM proteins is to facilitate cell adhesion, in which they 
serve as ligands for one or many of the heterodimeric transmembrane cell surface 
receptors, termed integrins [28].  
 
                                                
2 Portions adapted from Clarke et al. Colloid-matrix assemblies in regenerative medicine, Current Opinion 
in Colloid & Interface Science, 18 (2013) 393-405. Copyright Elsevier 2013. 
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Figure 1:  Schematic of the extracellular matrix. This cartoon illustrates the 
extracellular matrix proteinaceous structure found in tissues which cells interact 
with via cell surface receptors termed integrins. (Adapted from reference [171], 
Copyright Elsevier 2013.) 
 
While most ECM proteins are slowly assembled and synthesized by cells within 
the surrounding tissue, an exception is fibrin, which is formed quickly through the 
initiation of the coagulation cascade. During this process, polymerization of soluble 
fibrinogen by thrombin cleavage forms an insoluble fibrin clot [29]. It is also important to 
note that the ECM is naturally in a non-equilibrium state as cells are constantly 
remodeling the network through deformations induced by cell contractile forces and 
degradation induced by numerous proteases, including the matrix metalloproteinases 
(MMPs), in addition to synthesizing new protein components within the tissue structure. 
 Proteoglycans are major components of many ECMs, where they act as fillers, 
contribute elasticity within connective tissues, and are important in molecular transport 
through the ECM [30]. Proteoglycans have a protein backbone with one or more 
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glycosaminoglycans or linear carbohydrate polymers covalently attached to the core 
protein. They are often sulfated, rendering them negatively charged under physiological 
conditions. This charge allows them to mediate signaling and regulate the movement of 
molecules through the matrix by binding cations and water molecules. Similarly, 
Microgels are highly swollen with water and can be synthesized to contain ionizable 
groups within the network [31].  
Therefore the native ECM is an extremely complex, dynamic environment 
through which many cell fate processes are controlled. The fields of tissue engineering 
and regenerative medicine have sought to develop biomaterials capable of recapitulating 
the behavior of the ECM in the context of synthetic or biosynthetic hybrids of reduced 
complexity with the ability to regenerate severely damaged tissues either in vitro or in 
vivo remaining the primary goal. In addition, such materials can lead to the creation of 
accurate models to study cell behavior and fate under a multitude of environmental 
conditions. Hydrogels both synthetic and natural have been a main choice for ECM 
mimics because their mechanical properties and high water content resemble those of 
many tissues [12]. 
2.1.2 Engineering natural complexity into synthetic ECM mimicking materials3 
 As we know the ECM protein composition and structure can influence many 
important cell adhesion and signaling events. Synthetic systems lack essential ECM 
components, like integrin ligands, to foster cell binding and proliferation, and, therefore, 
require modification to include these molecules. Many have spent careers engineering 
strategies to overcome these challenges and incorporate complex biological moieties into 
                                                
3 Portions adapted from Clarke et al. Colloid-matrix assemblies in regenerative medicine, Current Opinion 
in Colloid & Interface Science, 18 (2013) 393-405. Copyright Elsevier 2013. 
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synthetic biomaterial systems [12, 13, 32-35]. While there are many different types of 
synthetic polymers that have been used as biomaterials in tissue engineering and 
regenerative medicine [36], here the focus will be on polymeric hydrogels. Hydrogels are 
a network of insoluble hydrophilic polymer chains that exhibit the ability to greatly swell 
in and retain water. Poly(ethylene glycol) (PEG) hydrogels have been extensively studied 
as candidates for tissue scaffolds because the hydrophilic nature of PEG prevents non-
specific protein adsorption.  
PEG acts as a blank scaffold where cell attachment, spreading, migration, and 
proliferation are mediated by specific molecules incorporated into the matrix. In the 
native ECM there are numerous sites for cell attachment, coupling cells and the ECM 
[37]. For this reason, cell-binding domains, the most common being RGD (the tripeptide 
Arg-Gly-Asp) [38], are often covalently bound to PEG networks to promote cell adhesion 
and motility. RGD represents the minimal integrin binding sequence found within many 
ECM molecules (fibrinogen, fibronectin) and is a convenient tripeptide used to 
functionalize many biomaterials [38-41].  In a typical example of this strategy, Gobin and 
West demonstrated the differing migration of human dermal fibroblasts (HDFs) in 
response to varying concentrations of RGD in synthetic ECM networks. With this 
approach, a balance must be struck between excessive ligand density, which may prevent 
cell detachment, and too low of a ligand density, where cells do not have enough 
adhesion sites for movement [42]. In further studies West and co-workers controlled the 
migration of human dermal fibroblasts in a three-dimensional PEG hydrogel by 
photopatterning a RGD peptide in defined spatial arrangements. HDFs moved in all 
directions when RGD was homogeneously incorporated in the network or in one 
 10 
direction when only the photopatterned RGD gradient was present [43].  
Additionally, for optimal success in vivo, synthetic materials must be rendered 
degradable to be fully integrated into a biological system. To meet this need and to 
decouple stiffness, pore size, and cell infiltration in synthetic hydrogels, investigators 
have engineered systems that enable cell-mediated degradation via protease-specific 
peptide crosslinkers [44-47]. This allows the material to maintain its scaffold shape and 
structure and only be structurally modified at points when cells degrade MMP sensitive 
cleavage sites in the gel backbone structure. These materials however rely on degradation 
for cell infiltration and thus can slow cell invasion and do not fully recapitulate native 
cell-ECM interactions. Hubbell and coworkers have demonstrated a biologically-inspired 
degradable matrix that incorporates MMP sensitive cross-linkers into PEG hydrogels [44, 
47]. MMPs are naturally secreted by cells to break down ECM components during wound 
healing and tissue growth/remodeling. Therefore, the MMP-cleavable PEG matrix 
degrades in response to cellular activity, thereby more closely mimicking native 
processes. Moreover, the degradation of matrix mimetic hydrogels has been shown to be 
an important factor in cell migration [42, 48] and stem cell fate [49], making the 
inclusion of degradation sites important in the design of new matrices. Hydrolytically 
degradable scaffolds, like poly(lactic acid) (PLA) or poly(glycolic acid) (PGA), have also 
been employed as transient matrices or to control the release of bioactive molecules from 
scaffolds [50, 51]. Unlike protease sensitive hydrogels, PLA/PGA hydrogels degrade 
under physiological conditions resulting in scaffold break down that is not controlled by 
cellular activity. A consequence to the use of these polymers is the creation of acidic 
degradation products, which can result in inflammation in surrounding tissues.  
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A number of biochemical cues exist in ECMs, which impact cell proliferation, 
migration, and differentiation of stem cells. For example, angiogenesis, a necessary 
process in tissue development, requires a combination of growth factors presented with 
temporal and spatial control to promote the successful growth of vasculature. Growth 
factors are present in ECMs as soluble signaling molecules and tethered to the ECM, 
where release is governed by protease activity [52] or force mediated release [53]. Due to 
the importance of growth factors in tissue development there has been a significant effort 
to produce systems capable of delivering or presenting growth factors in a controlled 
manner [54, 55]. PEG hydrogels have been extensively studied as releasing scaffolds 
[56]. Mooney and co-workers have also used PLA/PGA copolymer hydrogels to deliver 
vascular endothelial growth factor (VEGF) and an inhibiting antibody (anti-VEGF) 
simultaneously to localize angiogenesis to specific zones [57].  
Alternatively, growth factors can be covalently bound within synthetic scaffolds 
to influence cell behavior. West and colleagues immobilized basic fibroblast growth 
factor (bFGF) in a gradient within PEG hydrogels in addition to RGD. Inclusion of bFGF 
into the network enhanced smooth muscle cell (SMC) proliferation, and SMCs were 
found to align in the direction of increasing concentration of growth factor [58]. In native 
ECMs growth factors can be found bound within the network but are later liberated by 
cell secreted proteases. Similarly, Zisch et al. demonstrated the release of VEGF from 
PEG hydrogels using MMP degradable tethers. Thus growth factor release was governed 
by cell activity [59]. Efforts have also been made to enhance the binding of growth 
factors, as well as other proteins, through the incorporation of glycosaminoglycans into 
the matrix. One example is the addition of heparin, a sulfated glycosaminoglycan found 
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in ECMs, to PEG hydrogels to sequester molecules within the matrix and tune the 
release. Yamaguchi and Kiick fabricated a heparin-PEG gel, which was able to bind and 
control the release of bFGF. Growth factor release was sustained for over two weeks, 
while burst release was observed from a hydrogel lacking heparin [60].  
 In contrast to synthetic systems, protein based biomaterials derived from the 
extracellular matrix offer significant favorable benefits when compared to more inert 
materials, mainly enhanced endogenous bioactivity. In many systems, it has been shown 
that native matrix acts as a growth factor/cytokine depot, presents insoluble ligands and 
scaffolds biochemical cues in a way that enables synergistic signaling that can serve as 
cues to endogenous cells for recruitment to the site of injury for tissue repair and 
remodeling [27, 61, 62]. Natural ECM polymers (e.g. collagen, fibrin, hyaluronic acid, 
fibronectin, laminin) have cell adhesive domains present for binding, and can be 
degraded and remodeled using enzymes secreted by resident cells. In the case of fibrin, 
degradation products of the molecule have been shown to be pro-angiogenic [63, 64]. 
This is also mirrored by work from the Badylak group that has demonstrated the ability 
of the ECM degradation products from decellularized tissues used as regenerative 
scaffolds allow for the recruitment of pro-regenerative endogenous cell populations to the 
site of the implant [65-69]. 
2.1.3 Fibrinogen and Fibrin – The provisional matrix 
 Fibrinogen is the endogenous soluble blood clotting protein that circulates in our 
blood stream at a concentration of approximately 2.5 mg/mL. It is a 340 kD dimeric 
protein with three chains, Aα, Bβ, and γ [70]. Among these three chains are cell and 
growth factor binding regions, FXIII cross-linking sites, and enzymatic cleavage sites to 
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initiate the formation of insoluble fibrin. Pro-thrombin, also circulating in our blood 
stream is activated in response to the coagulation cascade (by clotting Factor X) and 
converted into active thrombin, which attacks fibrinogen molecules. Thrombin cleaves 
the fibrinopeptides (FpA, FpB) off of the fibrinogen N-terminal regions of the Aα and Bβ 
chains exposing ‘knobs’, which then are available to bind to complementary pockets 
(knob ‘A’ binds to hole ‘a’ and knob ‘B’ binds to hole ‘b’) on the C-termini of 
neighboring fibrin(ogen) molecules [71]. The molecules bind to one another and chains 
grow into protofibrils, which continually elongate and additionally begin to laterally 
aggregate [72]. Thrombin also activates the transglutaminase FXIII (forming FXIIIa), 
which aids in the formation of γ-glutamyl-ε-lysyl amide bonds between sites on the α and 
γ chains of adjacent fibrin(ogen) molecules. While it has been demonstrated that fibrin is 
an equilibrium polymer, when it is FXIII cross-linked, this process is halted completely 
and fibers must be proteolytically digested for dissolution to occur [73]. FXIII is thus 
known as a stabilizing factor, and with its ability to crosslink the α and γ chains of 
fibrin(ogen), a stronger more elastic clot is formed consequently [74, 75]. The activation 
of FXIII by thrombin exposes the active-site cysteine on the molecule, which enables the 
formation of γ-γ dimers within seconds (while α-α and α-γ crosslinks form more slowly 
as the clot matures) [76, 77]. Additionally, the crosslinking of other molecules such as 
fibronectin or α2 plasmin inhibitor into a fibrin clot occurs at a slower rate compared to γ-
γ dimerization [78]. Due to FXIII’s large binding constant for fibrinogen (KD ≈ 10-8), it 
circulates in the plasma mainly in association with fibrinogen and thus is often co-
purified with plasma-derived fibrinogen used in most commercial fibrin sealants [79, 80].  
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 It is known that several factors affect the formation of fibrin clots including 
fibrinogen concentration, thrombin concentration, calcium ions, and sodium chloride. 
Chloride ions are thought to interact with fibrinogen chains to inhibit or diminish 
molecular lateral aggregation during fibril formation, thus clots formed in the presence of 
lower salt concentrations generally produce thicker fibers [81]. Conversely, clots formed 
in high salt concentrations form translucent more highly branched networks with thinner 
fibers. It is also known that differences in fibrin fiber morphology affects clot mechanical 
properties. Thus, depending on the thrombin and/or calcium chloride concentration used 
during polymerization, clots of the same initial fibrinogen concentration can display 
dramatically different architectures. With respect to mechanical properties however, there 
is a balance between mesh size and fiber thickness, where the most mechanically robust 
clots come from gels with intermediate thrombin and calcium concentrations (thus 
intermediate fiber thicknesses and porosities) [82]. Additionally, clots with thinner fibers 
with more branching typically are less susceptible to lysis compared with those 
containing thicker fibers with more porous networks. This is typically related restricted or 
hindered diffusion of proteolytic molecules into these dense matrices.  
 Fibrin and its precursor, fibrinogen, present binding sites for other pro-coagulant 
proteins (thrombin and Factor XIII), pro-fibrinolytic proteins (plasminogen, tissue 
plasminogen activator), anti-fibrinolytic proteins (plasminogen activator inhibitor), 
growth factors (VEGF, PDGF, bFGF), ECM glycoproteins (fibronectin, heparin), and 
cell surface receptors (integrins, cadherins) [61, 83]. All of these components make up a 
network that is capable of transitioning the provisional wound network into a healed 
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tissue structure. During tissue repair, invading cells are able to migrate into the fibrin 
matrix and degrade/remodel the polymer over time [84]. 
2.1.4 Fibrin in wound healing and tissue engineering 
 As a classic example, fibrin serves as the provisional matrix formed at the site of 
injury through enzymatic activation with thrombin in response to the coagulation cascade 
[70, 83]. It initially aids in the process of halting bleeding, but then serves as a scaffold 
for regeneration, subsequent cell infiltration and tissue repair. Clinically, fibrin is used at 
supraphysiological concentrations (> 10 fold) as a hemostatic agent in events of trauma 
and as a sealant to glue tissues together or seal wounds [29, 85-87]. Fibrinogen can be 
conveniently isolated from serum proteins and is used clinically as a tissue sealant in 
combination with its activator, thrombin. It has also been extensively studied as a tissue 
construct for regeneration of many tissues including cardiac, muscle, skin, vascular and 
bone [88-90]. Current FDA-approved fibrin sealants on the market such as Tisseel® 
(Baxter Healthcare) and Evicel (Johnson & Johnson) typically contain supra-
physiological fibrinogen concentrations ranging from 20-100 mg/mL, while the native 
human clot is approximately 2-4 mg/mL [7, 91]. In clinical formulations, fibrin sealants 
typically contain concentrated fibrinogen and thrombin in addition to FXIIIa [80], and 
fibronectin which are often co-precipitated with fibrinogen due to their high binding-
affinity for the molecule [88, 92]. Additionally, these formulations are often 
supplemented with aprotinin, a protease inhibitor (which inhibits several serine proteases, 
including plasmin), which will allow for longer-term maintenance of the fibrin clot in 
vivo once it is exposed to the highly active enzymatic microenvironment [63, 93, 94].  
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 When fibrin is utilized at these high concentrations, a dense matrix with 
nanometer scale pore size is formed, which is difficult for cells to infiltrate without 
significant degradation of the polymer [16, 86, 87, 95].  A basic study of neutrophil 
chemotaxis in various fibrin sealant clot formulations demonstrated that chemotaxis 
driven cell migration through clots at concentrations as low as 5 mg/mL were 
significantly dense enough to inhibit migration [16]. More specifically, when fibrin was 
used at high concentrations in a chorioallantoic membrane (CAM) assay to visualize 
blood vessel development, it was observed that cells were unable to directly invade the 
dense fibrin gel [96]. The CAM tissue degraded fibrin only along the polymer surface 
and replaced it with vascularized neo-tissue. 
 Not only is fibrin fundamental in hemostasis, but it also serves as a biologic 
scaffold that binds a multitude of factors, concentrating them to the wound 
microenvironment to enhance subsequent repair of the damaged tissue. However, if fibrin 
deposition and degradation processes are imbalanced (e.g. due to supra-physiological 
concentrations of fibrinogen), then cellular infiltration, ECM remodeling, and ultimately 
regenerative processes are hindered [84, 95, 97]. Mechanical and diffusional limitations 
of these supra-physiological clots impede cellular infiltration and remodeling [84, 96]. 
However, in order to generate fibrin gels with mechanical properties similar to osteoid for 
bone repair applications for example, or other applications requiring materials with an 
elastic modulus larger than a few hundred kilopascals, high concentrations of protein are 
necessary, resulting in networks that are extremely dense. Consequently, it has been 
shown that these concentrations can lead to poor regeneration of bone tissue in vivo [15]. 
The same issues hold for fibrinogen based tissue sealants that are used at high 
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concentrations to facilitate rapid wound closure, but then subsequently prevent host cell 
infiltration and remodeling [16].  
PEG-fibrin constructs have also been investigated by groups in order to maintain 
the bioactivity of the fibrinogen molecule, while simultaneously taking advantage of the 
more robust mechanical properties, density, and biodegradability associated with PEG 
[62, 98-100]. Fibrinogen is PEGylated, purified, and polymerized into hybrid gels either 
through crosslinking of PEG or addition of thrombin, and these constructs have been 
shown to support cell adhesion and spreading. However, the constructs rely on higher 
PEG concentrations in order to produce the most mechanically robust gels (with Young’s 
moduli >5-10 kPa). Thus, their ability to sustain complex morphogenetic processes such 
as angiogenesis in gels of increasing modulus has not yet been realized due to the strong 
dependence of network formation on gel crosslinking density [98, 101, 102]. In efforts to 
modulate the molecular architecture of PEG-fibrinogen gels, nanostructured composites 
were formed by incorporating Pluronic® F127 micelles into precursor gel solutions [103, 
104]. Hydrogel network assembly was altered, however the micelles only had a modest 
effect on cell spreading in this system. PEG-fibrin constructs have been engineered in the 
Sugg’s group using amine-reactive PEG to PEGylate fibrinogen [105, 106]. These same 
constructs have shown the ability of adipose-derived stem cells to undergo tubular 
network formation in PEG gels – thus simulating a crude form of angiogenesis. However, 
the structure of these gels has not been well characterized and their mechanical properties 
are on the order of 100s of Pascal’s [107]. Thus, in order to be used in applications where 
stronger mechanical properties would be desired, the PEG or fibrin concentration would 
need to increase – thus limiting the mesh size and subsequent cell migration.  
 18 
2.1.5 Challenges in biomaterial-host tissue integration 
 In order for an implanted or in situ forming biomaterial to maintain viability in 
vivo, the material and host tissue must interact at the interface. One of the crucial 
requirements for subsequent regenerative success is access to a blood supply for nutrient 
and waste exchange [108]. Previous work in the field has demonstrated that for cells 
within a material to remain viable, they must be within 200 µm of a vessel. Thus, the 
material must have a pre-templated vascular supply that can somehow anastomose with 
the host vasculature, or native cells must be able to infiltrate the material in order to 
establish its own supportive structures through angiogenesis and vascular sprouting. 
When studying host-biomaterial interactions, it is important to understand what will 
happen at the interface of the material and native tissue. Much work within the field of 
biomaterials has looked at the body’s endogenous response to implanted synthetic 
materials [109-112]. Through this work it has been learned, that when a solid material is 
implanted in the body, the endogenous cells respond to the implant as non-self and the 
immune system undergoes what has been termed the foreign body reaction. The immune 
reaction starts upon material implantation where the acute response results in the 
recruitment of mononuclear leukocytes and neutrophils. Next they are followed by 
macrophages, which appear in increasing number in the chronic phase, while later 
fibroblasts infiltrate contributing to granulation tissue formation and fibrosis [109, 113]. 
At the implantation site, immune cells survey the area, and macrophages interact with the 
surface of the material. In efforts to ‘eliminate’ the foreign body, a key function of 
macrophages against bacteria and other small pathogens, the macrophages attempt to 
engulf the material. However, they are unable to do so and undergo ‘frustrated 
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phagocytosis’. This results because the implant is likely much larger than the individual 
cells are capable of engulfing and thus it must be degraded to be removed (but many 
implants/devices are non-degradable). These frustrated phagocytic cells become large 
multinucleated foreign body giant cells, which completely surround the implant site. 
Subsequent steps of excessive matrix deposition and recruitment of activated fibroblasts 
result in the implant being effectively isolated and walled off from the host. Thus, this 
response must be overcome or manipulated when the desired therapeutic outcomes relies 
on interaction of host cells or tissue with the implant. Porous materials or those 
susceptible to degradation have been shown to mitigate this response in some cases, as 
they allow for macrophage and other immune cell infiltration/exploration within the 
material (and thus stave off foreign body giant cell formation and fibrous encapsulation) 
[114]. However, mechanisms of cell infiltration are still being studied in many systems. 
When studying cell infiltration and motility, for physical entry of the cells into the 
implant, there lies a delicate balance between the pore size of the matrix/material and the 
degradation of that material.  
2.1.6 Modulating the pore size of biomaterials 
 The extracellular matrix provides the protein scaffold for which cells reside in 
native tissues. Typically, it has been shown that interstitial connective tissues comprised 
of mostly collagen have pore sizes range from 2-30µm [115, 116]. Biomaterials 
generated from natural ECM proteins (such as fibrin, collagen, matrigel, etc) are largely 
capable of recapitulating pore sizes on this same scale. However, when utilized at 
supraphysiological levels, these native protein gels can take on much smaller pore sizes. 
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The pore size of synthetic materials largely depends on the molecular building 
blocks of the system, or the method in which the material is generated. Thus, the pore 
size of the network in some cases is equivalent or on the same relevant length scale as the 
size of a monomer. Since most synthetic hydrogels have pore sizes on nanometer scale 
[46], there is a need for engineering of proteolytic degradable sites within the polymer 
backbone. Although great strides have been made in the development of cell-degradable 
polymers, in normal wound repair, regeneration, or embryonic development, matrix 
degradation is not a natural requisite to migration and invasion.  Matrix degradation 
enables slow but persistent cell invasion into dense matrices, but most interstitial 
connective tissues allow for convenient migration through having much larger pore sizes 
[116]. Additionally, in the native ECM, the inclusion of high Mr proteoglycans within a 
more porous protein fibrillar mesh helps define the submicron pore size length scale, 
resulting in physically robust elastic materials with an inherent flow behavior at length- 
and time-scales relevant to cell invasion; this results in their permissive nature. 
Alternatively, a bulk gel can be generated from a material with a small pore size 
around a network of sacrificial microparticles, which can be degraded away, resulting in 
an interconnected porous network of tunable sizes. Work from the Ratner group has 
determined design parameters of porous scaffolds for optimal biointegration and 
angiogenesis [117, 118]. However, most systems for formulating microporous scaffolds 
rely on either 1) photo-patterning [119] or 2) microsphere incorporation into the base 
scaffold during polymerization for subsequent microsphere degradation (with harsh 
solvents such as acetone [120]) and removal [89]. Furthermore, fibrin scaffolds for 
clinical use have an average pore size of ~ 100-600 nm [46], which is substantially below 
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the values that were found to be most amenable to angiogenesis and cell infiltration [114, 
120]. It is clear from this that a potential exists to improve the regenerative properties of 
fibrin. Additionally, these current strategies to increase porosity lack the potential for in 
situ (i.e. injectable, shape-molding scaffold, during surgical procedures) scaffold 
formation for wound repair.  
It has demonstrated that through engaging fibrin polymerization with ‘b’-knob 
conjugates, a more porous structure can be formed with an increase in gel complex 
modulus, yet no significant differences in angiogenesis were displayed in a microvessel 
fragment sprouting assay [7]. Additionally, we have found this effect diminishes with 
increasing fibrinogen concentration. Therefore, fibrin(ogen) concentration is still the 
single most dominant factor in determining gel mechanical properties, raising the need 
for new strategies to modify this base scaffold for regenerative medicine. 
2.1.7 Factors influencing 3D cell migration 
Migration of interstitial cells is a multi-step process that relies on the 
physiochemical balance between cell deformability and physical tissue constraints [115]. 
Both chemical and physical properties of tissue composition and structure will influence 
these processes, including protein/molecular content, assembly and crosslinking state of 
the matrix [121-123], physical scaffold geometry and alignment (and thus the resulting 
pore size) [124, 125], and finally tissue stiffness [126]. During migration, initially, there 
is pseudopod protrusion at the leading edge of the cell driven by actin polymerization, 
which results in subsequent integrin-mediated adhesion to the ECM. Next proteases 
cleave ECM molecules in a contact dependent manner and contract their cell body in an 
actomyosin-mediated process to increase their tension [116]. Finally, the rear of the cell 
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retracts and the cell is able to translocate its body to move forward and migrate [127-
129].  
The mesh or pore size serves as a critical factor to help define the permissiveness 
of a material to enable 3D cell migration. Endogenous cells harness both proteolytic and 
non-proteolytic mechanisms to migrate through tissues, and they largely respond to cues 
from the external microenvironment to dictate their modes of migration [130]. It has been 
shown that metastatic cells can switch between an elongated mesenchymal migration that 
is adhesion dependent and an amoeboid adhesion independent phenotype [131-133]. 
Petrie and co-workers demonstrated that the elastic behavior of the ECM can also 
influence the migratory phenotype of fibroblasts, where activity of RhoA and linear 
elasticity of the matrix can switch cells between a lamellipodial based 3D migration and 
lobopodial-based migration [134]. Additionally, more recent work studying cells in 
confined microenvironments has further demonstrated how the effects of biophysical and 
biochemical can dictate these processes. It has been observed that typically slow 
mesenchymal cells can switch their migratory phenotype to an amoeboid-like stage under 
circumstances of low adhesion and high cortical contractility [130]. Wolf et al. 
demonstrated that cells are incapable of non-proteolytically migrating through pores 
smaller than ~10% of the diameter of their nucleus [115]. This comes out to a range of 
approximately 2-6 µm in diameter dependent on the cell type that is used and the 
associated nuclear deformability. Additional studies have confirmed the importance in 
the deformability of the nucleus in cell migration [135], specifically that nuclear lamin 
stiffness can be a barrier to motility [136]. Thus, there exist optimal matrix architectures 
that remain to be realized, displaying variable adhesivity and stiffness, from which cells 
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can harness these properties for angiogenesis and cell infiltration for improved 
biomaterial-host tissue integration.  
In synthetic materials, cell migration is strongly influenced by the degradation 
properties of the matrix. Many biocompatible synthetic hydrogels degrade slowly via 
mechanisms such as hydrolysis, which enable them to maintain their structure and shape 
for longer periods of time in vitro and in vivo. However, synthetic hydrogels such as PEG 
which have pore sizes on the nanometer scale, and in order to permit cell motility, must 
be engineered to possess proteolytically cleaveable sites within the polymer backbone. 
Specific examples of these types of materials are described in section 2.1.2. This then 
enables network to degrade enough for cells to extend protrusions, spread, and initiate the 
same migration paradigm described above.  
2.2 Microgels in regenerative applications 
2.2.1 Fundamentals of microgels – chemical and physical properties 
 Microgels are colloidal hydrogel microparticles consisting of intramolecularly 
crosslinked polymers swollen by a good solvent [137]. These materials can be solid-like 
similar to traditional ‘hard’ colloids, but also portray the soft deformable properties 
inherent to many polymer systems. In contrast to solid colloidal particles such as those 
made from polystyrene or silica, microgels are stimuli responsive and able to change size 
by absorbing solvent through balancing internal and external osmotic pressures within 
their environment [137, 138]. The swelling properties of a microgel can be tuned through 
changing the solubility of the microgel polymer in the solvent. This can often be achieved 
through changing temperature or the chemical composition of the polymer backbone if 
there are ionizable groups present. Due to their more complex swelling properties 
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compared to hard spheres, microgels can display a rich range of behaviors. For example, 
the optical properties of microgels are unique and of interest because as the microgel 
becomes more swollen, its refractive index will converge towards that of the solvent 
[138]. However, as the particle becomes more deswollen by external stimuli, the 
microgels will deswell and thus increase their refractive index and at sufficient 
concentrations give rise to turbidity [139].  
 When thinking about the phase behavior of traditional hard spheres, volume 
fractions above ϕ = 0.55 are considered within the crystalline regime and the densest 
close-packed arrangement of colloids (which is quite rare) corresponds to ϕ = 0.74 [140]. 
Microgel swelling (or de-swelling) in response to environmental stimuli gives rise to 
complex phase behavior as the packing of microgels can theoretically reach volume 
fractions greater than one due to their deformability and ability to de-swell (which can be 
temperature, pH, or concentration dependent) [22]. It is also thought at sufficiently high 
volume fractions, microgels are so closely packed that interpenetration between adjacent 
particles can occur. Additionally, microgels of different polymer cross-linking densities 
(and thus stiffness) are able to display unique properties that have allowed for a better 
understanding of molecular glass formers and the glass transition. In work by Mattson et 
al, it was demonstrated that the fragility of a microgel suspension is dictated by the elastic 
properties of the microgel at the single particle level. Thus, the softer the particles, the 
stronger the suspension behavior, which corresponded to weaker growth of the elastic 
energy as packing fraction is increased [141]. The rheological properties of microgels are 
also unique when compared to those of hard spheres. Nanopore and micromechanical 
experiments have illustrated the deformability of microgels through observation of their 
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change in shape and volume under an applied stress [142]. These fundamental aspects of 
microgels that are enabled by the physiochemical properties of their structure allow for a 
wide array of possibilities for the application of microgels in many biomedical 
therapeutic strategies. 
2.2.2 The use of microgels in biomedical applications 
 Colloids have been widely used in biomedical research due to their ease of 
synthesis, multi-functionality, and unique properties. More specifically, colloids have 
been heavily studied in the field of drug delivery, where they have served as carriers for 
small molecule therapeutics and biomacromolecules. Efforts have been focused on the 
development of formulations for intravenous administration for systemic circulation and 
release at a site of interest [143-150]. Display of ligands of the surface of the colloids 
allows for tunable targeting of microgels to therapeutic target receptors. Additionally, 
microgels have been employed to generate drug-eluting coatings or non-fouling surfaces 
on the surface of biomedical implants [151-153]. Colloids have also been utilized in 
modular systems in order to achieve structural complexity in addition to diversely 
patterned tissues [154-156]. As the next section will detail, colloids have the potential to 
provide a means of tailoring the mechanical properties of biologically derived hydrogels, 
which are easier to integrate into tissues than purely synthetic architectures. 
2.2.3 Colloid reinforced matrices and composite gel systems4 
 Traditional synthetic hydrogels exhibit tunable mechanical properties that are 
similar to that of many tissues, making them widely studied for tissue engineering and 
                                                
4 Portions adapted from Clarke et al. Colloid-matrix assemblies in regenerative medicine, Current Opinion 
in Colloid & Interface Science, 18 (2013) 393-405. Copyright Elsevier 2013. 
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regenerative medicine applications. Reductionist ECMs, like collagen or fibrin gels, are 
useful for soft tissue applications where the elastic modulus needs to be on the order of 
Pascals to several kiloPascals. However, for tissues like bone, cartilage, and muscle, 
hundreds of kPa are required for proper cell growth, phenotypic maintenance, and tissue 
development [1]. A common issue in reductionist and synthetic ECM approaches is that 
the gels are often not mechanically robust enough for load-bearing tissue applications 
[157]. One of the primary challenges remaining in tissue engineering and regenerative 
medicine is the development of biomaterials that display robust mechanical properties 
while simultaneously being permissive to cellular invasion. It is currently typical that one 
can optimize either feature independently, but optimization of both simultaneously 
represents a significant challenge. A possible solution to increase the elastic modulus is to 
increase the polymer concentration or the number of crosslinks in the gel. However, this 
approach can be limiting, as simultaneous changes in gel porosity and, in some cases, 
ligand density influence material mechanical properties, cell migration and diffusion of 
molecules within the gel [158, 159]. For example, the ability to increase in the modulus 
of poly(ethylene glycol) (PEG) hydrogels without affecting mesh size has been 
demonstrated [160]; however, the mesh size is still on the order of tens of nanometers, 
which is not cell permissive. 
 Over the last few years, design of many new nanocomposite hydrogels for 
biomedical applications in regenerative medicine, biosensors, and drug delivery has 
gained interest in the biomaterials community [161]. In this new research area, various 
types of nanoparticles (including carbon-based, polymeric, ceramic, metal, etc.) are 
combined with a polymeric network where the particles either physically or covalently 
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interact with the hydrogel network to form a hybrid material. Many of these new 
composites or hybrids display novel functions and have the potential for further 
modifications/tuning to the application of interest.   
 One approach has been to develop synthetic additives that can increase the elastic 
modulus of hydrogels. This has been accomplished through the development of double 
network hydrogels and colloid reinforced hydrogels. Haraguchi et al. demonstrated the 
reinforcement of a poly(N-isopropylacrylamide) hydrogel by using inorganic clay disks 
as the crosslinking points within the gel [162]. A similar effect has been observed in 
poly(ethylene oxide) (PEO) hydrogels [163]. Additional approaches regarding 
nanoparticle-based reinforcement in composite materials have also been reported [164, 
165]. In these nanocomposite gels, particles act as cross-linkers within the bulk gel, 
enhancing the mechanical toughness beyond that expected for traditional organic cross-
linkers. Importantly, the presence of particulate cross-linkers creates more porous 
networks unlike their small molecule counterparts, which decreases the pore size of the 
gel as the cross-linker concentration increases. As natural ECMs are porous scaffolds, the 
incorporation of colloidal particles into synthetic ECMs could better mimic the native 
microstructured environment while simultaneously enabling controlled modulation if its 
mechanical properties.  
 While hard, inorganic particles have been successful in enhancing the elastic 
modulus of hydrogels, soft hydrogel colloids have also become a promising route [166]. 
A study reported by Richtering and co-workers demonstrated that temperature-responsive 
hydrogel microparticles (microgels) simply embedded in a hydrogel matrix resulted in a 
modest increase in the elastic and storage moduli and the strain and stress at break. 
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Temperature induced de-swelling of the particles resulted in a transformation from soft to 
hard particles, further enhancing the mechanical properties of the composite gel. An 
additional consequence of the induced volume change is the generation of a matrix with 
switchable porosities [167]. Saunders and co-workers have reported enhanced mechanical 
properties by chemically crosslinking stimuli-responsive microgels into a hydrogel 
network [168, 169]. Importantly, these doubly cross-linked µgel networks were shown to 
function in a load-bearing application: the reconstruction of deteriorated intervertebral 
discs. Degenerated discs injected with doubly cross-linked microgels had mechanical 
properties similar to those of normal intervertebral discs [170]. The authors proposed that 
the doubly cross-linked µgel network increased the swelling pressure within the discs 
because of the high water content, permitting the discs to behave in a manner similar to 
the natural system of collagen and proteoglycans – where collagen is the structural unit 
and the highly charged proteoglycans provide internal swelling osmotic pressure. Overall, 
biomaterial micro- and nanocomposites represent a growing area in regenerative 
medicine where there is much to gain through engineering colloid-matrix assemblies 
[171].  
2.2.4 Ultra-low crosslinked microgels 
Ultra-low crosslinked (ULC) poly(N-isopropylacrylamide) microgels are soft 
deformable microgels of approximately 500 nm radius. Their synthesis is based on 
precipitation polymerization without the presence of exogenous crosslinker, under 
reaction conditions that favor chain transfer. This allows NIPAm oligomers to self-
crosslink and form soft, loose microgels [172, 173]. The addition of the co-monomer 
acrylic acid adds a negative charge to the microgels. This negative charge can then be 
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utilized for non-covalent binding of positively charged proteins with tunable release 
kinetics for therapeutic delivery [174]. As a result of their inherent softness, microgels 
can be concentrated above random close packing to form a space-filling colloidal glass 
[22].  Microgels in general are considered colloidally stable and demonstrate a strong 
resistance to aggregation because the surface of the particles often contains charges and 
‘hairy’ surface chains [175]. Their ability to be lyophilized and easily re-dispersed in 
water additionally highlights their stable properties compared to other colloids. PNIPAm-
based materials have been extensively studied for tissue engineering and drug delivery 
applications due to their thermoresponsivity, and studies have demonstrated the polymer 
and its degradation byproducts do not elicit cytotoxicity [176, 177].  Synthesis of 
microgels containing alternative polymers is additionally possible allowing one to pick 
and choose their base polymer of choice. The rheological properties of microgel 
suspensions are the focus of both fundamental and industrial applications and can be 
controlled to meet specific requirements by modifying their concentration, size, shape, 
cross-link density, surface properties, and solvent quality [178, 179].  Additionally, 
further characterization of the deformability of ultra soft microgels has been performed, 
and the size and acrylic acid content of these deformable microgels has been tuned [180]. 
2.2.5 Mechanisms of the formation of colloidal gel networks, i.e. depletion 
 Colloidal gelation and the formation colloidal networks that take on fractal 
morphologies is an entire field of study within soft condensed matter. Many different 
types of stimuli can initiate colloidal gelation. However, one method of induction is 
based on the entropic phenomenon of depletion. This phenomenon occurs between two 
larger colloids (order of microns in diameter, for example) that are surrounded in a 
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suspension of other smaller colloids (or depletants, on the order of nanometers in 
diameter). Depletion is a net attractive force between these two larger colloids of interest 
that are driven together based on an osmotic pressure induced by the smaller colloids. 
Under normal conditions, the space between the two larger colloids is large enough to fit 
a smaller particle, i.e. the diameter of a smaller colloid within the system. However, due 
to entropy and thus the desire for the smaller colloids to occupy more volume, the two 
larger colloids are brought together increasing the effective volume of the smaller 
colloids. This phenomenon has been described in detail for hard sphere colloids [181] and 
the interaction potential of the larger colloids is related to the volume fraction of the 
depletant and the size of the two constituents. If the interaction potential is on the order of 
kBT, then the interaction is not strong enough to sustain clustered particles and thermal 
fluctuations will release the transient interactions the particles may encounter. However, 
is the interaction potential is substantially large, i.e. > 5-10 kBT, then depletion will be 
expected to occur and the larger colloids will interact, flocculate, and grow into colloidal 
gel networks throughout the system. Others have mixed non-adsorbing polymers with 
colloidal suspensions to induce an effective attraction between the particles to generate 
fluids of clusters [182]. While these studies give insight to food and cosmetic/personal 
applications where colloidal stability of products is critical, rich information regarding 
the physics of these interactions can be gained. Additionally, although often overlooked, 
the depletion attraction force has many implications in cell biology/intracellular 
organization, as the molecularly crowded environment likely gives rise to these 
attractions and drives assembly between larger proteins/complexes within the cell [183]. 
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2.3 Angiogenesis and vascularization of implanted materials 
2.3.1 Angiogenesis 
 Vascularization is defined as the process of becoming vascular – or the 
development or extension of blood vessels. There are several designations of 
vascularization that are important to distinguish between when considering blood vessel 
formation in various biological processes. Vasculogenesis is the de novo formation of 
new vessels from endothelial cells and is generally thought to only occur in the 
developing embryo, where mesoderm-derived endothelial precursors (angioblasts) fuse to 
form a primitive capillary plexus [184, 185]. However, there exists controversy in the 
field, as there have been recent studies in the literature suggesting circulating or bone-
marrow derived endothelial progenitor cells may contribute to adult vasculogenesis [186-
188], while results from other studies contradict this fact [189]. Ateriogenesis is the 
growth of functional collateral arteries from pre-existing arterio-arteriolar anastomoses 
that is normally triggered by physical forces such as altered shear forces [190]. 
Angiogenesis is the process in which new blood vessels sprout from existing blood 
vessels. Distinct biological triggers occur to stimulate angiogenesis such as tissue 
expansion (for example, in growing tumors) and hypoxic tissue microenvironments. In 
response to hypoxia in tissues, hypoxia-inducible transcription factors (HIF) bind to 
enhancer elements in the promoter region of certain genes to regulate expression. Of 
particular importance is VEGF, which can increase its expression up to 30 fold within 
minutes [191].  Sprouting is initiated by these angiogenic signals from the surrounding 
tissue, including growth factors like VEGF and chemokines released from an 
inflammatory cell [192]. Pericytes will detach from the surrounding vessel basement 
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membrane via proteolytic digestion (regulated by MMPs), the endothelial cells will 
loosen their junctions, and the vessel will dilate. This dilation and VEGF signaling to the 
endothelial cells causes the extravasation of plasma proteins such as fibrinogen and 
fibronectin, which will form an ECM surface for endothelial cells to migrate. Subsequent 
proteolysis of matrix in the surrounding area will liberate additional nascent pro-
angiogenic growth factors bound to the matrix such as VEGF and FGF. As the 
angiogenic tube lengthens, one cells is designated as the tip cell to lead the way and 
degrade the matrix as it infiltrates the surrounding tissue. Complex signaling pathways 
critical to a detailed molecular understanding of angiogenesis are described elsewhere 
[185] and designate cells on either side of the tip cell as stalk cells, which divide in order 
to maintain cell junctions and advance the growing vessel forward.  
 Therapeutic angiogenesis or therapeutic vascularization is a regenerative strategy 
focused on targeting blood vessel infiltration and reperfusion of ischemic tissues. Due to 
the high number of people with peripheral artery disease [193] and those with coronary 
heart disease [194], engineering strategies to promote therapeutic vascularization 
represents a significant area of research in regenerative medicine [195-199].  
2.3.2 Collective cell migration and mechanisms endothelial cell migration 
 Collective cell migration is a process in which groups of cells engage in modes of 
motility together as a unit. The three main points central to collective cell migration are 
as follows: 1) the functional and physical connections between the cells are maintained 
and the integrity of the cell-cell junctions are kept during motion, 2) supracellular 
organization or polarity is maintained within the group of cells, and there is a global 
organization of the actin cytoskeletons among the cells, 3) groups of moving cells 
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structurally modify the matrix into which they move through degradation and subsequent 
remodeling with deposition of new ECM [200-202]. In vivo, many developmental and 
wound healing processes utilize collective cell migration to respond to environmental 
cues and mobilize groups of cells to perform a specific function. Examples of processes 
in which collective cell migration occurs include branching morphogenesis (morphogenic 
duct/gland formation, i.e. mammary gland), cancer metastasis (multicellular 3D invasion 
strands, or a detached cluster of cancer cells), 2D sheets (epithelial development and 
wound healing), and vascular sprouting, to name a few.  
 During the collective cell migration of vascular sprouting in newly forming or 
regenerating vessels, collections of 3D strands will invade the provisional fibrin-
fibronectin matrix in the wound microevironment. Migration is initiated by the tip cell, 
which exhibits many filopodial protrusions to probe the surrounding matrix, degrade it 
where necessary, and allow for subsequent matrix remodeling and deposition to form a 
track for stalk cells and the vessel behind it to follow. Stalk cells are connected to each 
other and the tip cell through VE-cadherin cell-cell junctions. VEGF is the most potent 
pro-migratory factor for endothelial cells during angiogenesis and the signaling pathways 
and mechanisms are described in more detail elsewhere [203]. 
 It is known that the extracellular microenvironment, specifically the ECM 
structure and mechanical properties, can influence the modes of cellular migration [130, 
134]. In fact, it has recently been shown that ECM density can influence a switch 
between single cell migration versus collective cell migration in in vitro cancer cell 
invasion models, where higher density ECM networks generated more invasive collective 
cell strands compared to individual migratory cells [204]. Thus, not only does cell type 
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and cell-specific properties influence cell motility, but there is also a role for ECM 
organization to influence cell fate. 
2.3.3 Engineering strategies for enhancing vascularization 
 Due to the need to develop strategies to vascularize biomaterials, many 
investigators have explored this field. The main strategies that have been explored 
include pre-fabricating vessel conduits, embedding vascular cells within materials upon 
implantation to enable microvessel network formation and anastomoses with host 
vasculature, and engineering degradable synthetic matrices with growth factors to recruit 
endogenous cells to invade the matrix. Miller and co-workers developed a method to pre-
form vascular networks using 3D printing. In this system, 3D complex grid networks 
were printed using a carbohydrate glass [205]. A hydrogel was then formed around the 
3D printed sugar structure. Flowing water through the conduits then resulted in the 
dissolution of the sugar creating an open vessel network within the hydrogel biomaterial. 
Subsequently, cells could be embedded in the hydrogels or seeded within the vessel 
conduits to form multicellular vascularized tissues. Additionally, other patterning 
techniques were used to demonstrate enhanced cell viability in larger gel constructs and 
enable anastomoses with host vasculature upon in vivo implantation [206, 207]. 
 Human umbilical vein endothelial cells (HUVECs) have been studied over the 
past 25 years and shown the ability to spontaneously form vessel networks in vitro when 
culture with ECM hydrogel substrates [208-210]. Additionally, primary microvessel 
fragments isolated from digested adipose tissue have been extensively studied [211-217]. 
These multicellular fragments containing endothelial cells, pericytes, and red blood cells 
have been shown in culture to form interconnected networks and anastomose with host 
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vasculature in vivo. One could imagine an autologous or allogeneic therapy where fat is 
isolated, digested, and capillaries are acquired, minced, and embedded within a hydrogel 
for tissue engineering or soft tissue reconstruction. Thus, this represents an interesting 
alternative to pre-fabrication of vessel conduits, where implanted cells form the networks 
on their own in response to microenvironmental stimuli.  
 Many groups have investigated the release of growth factors, in particular VEGF, 
from dense biomaterials in order to provide a vascular signal to endogenous cells to 
induce angiogenesis within an implanted material or ischemic tissue [218, 219]. 
However, VEGF delivery has not yet been translated into the clinic successfully – as the 
dose, duration, and delivery method of VEGF needs tight control. This is critical to the 
therapeutic outcome, where low levels or a short half-life of VEGF will result in no 
benefit and high levels of VEGF can cause aberrant angiogenesis (preventing stable 
vessel formation) [220, 221]. Hubbell and co-workers have worked to overcome this 
challenge through utilizing the native ECMs ability to bind growth factors as a delivery 
vehicle in both natural and synthetic systems [8, 199, 222]. Additionally, work from 
Phelps et al. demonstrated the ability to incorporate tethered VEGF121 for controlled 
release from RGD modified PEG-DA hydrogels, where increased material 
vascularization was observed in groups containing VEGF [223]. Work from West and co-
workers illustrated the in growth and formation of blood vessels in three-dimensional 
engineered MMP-degradable VEGF-loaded PEG gels both in vitro in a co-culture of 
HUVECs and 10T1/2 cells and in vivo when engineered gels were implanted in mouse 
cornea [224]. More recently, Sacchi et al. demonstrated an increase in vascularization of 
long-lasting fibrin implants that were engineered with a degradable protease inhibitor 
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sequence. When degradation and release of recombinant VEGF164 from the construct was 
tuned to optimal levels, they were able to achieve functional and stable vessels 
demonstrated when implanted intramuscularly [9]. While a few groups have displayed 
some success in certain pre-clinical models and systems, there is still work to be done to 
determine how these therapies can ultimately be translated to the clinic in a safe, 
efficient, and cost-effective manner. Thus, inducing vascular growth into materials for 
regeneration remains an important challenge within the field that will likely not be solved 













CHAPTER 3  CHARACTERIZATION OF ULTRA LOW 
CROSSLINKED MICROGELS AND FIBRIN-MICROGEL 
HYBRID CONSTRUCTS 
3.1 Introduction 
 There is a great need to generate materials-based strategies for regenerative 
medicine and tissue engineering where implanted materials can quickly and easily 
integrate with host tissue and to enable the establishment of a functional vasculature. In 
this work, fibrin was used as a model system, as it is a relevant ECM scaffold that is often 
utilized due to its endogenous bioactivity and its prevalence in the wound 
microenvironment as the native provisional matrix. Drawing inspiration from 
proteoglycans within the native ECM, which have a space-filling role and are water-
swollen structures that add compressive strength to tissues, microgels were added to 
dense fibrin matrices to mimic these properties and promote enhanced cell infiltration and 
vascularization. Thus, the generation of composite fibrin-microgel constructs was 
explored. The hypothesis of this aim was that microgels would form interconnected 
structures within fibrin gels and that the mechanical properties of the composite would be 
maintained at the same levels as the fibrin alone gel. 
 The objective of this aim was to study the effects of adding various concentrations 
of microgels to high concentration fibrin gels (at fibrinogen concentrations where normal 
cell motility and infiltration were inhibited). In order to do this, a careful characterization 
of the microgels used in this system was completed. This included size measurements of 
the particles including both the hydrodynamic radius and radius of gyration. Additionally, 
microgels with varying crosslinking density were investigated. Specifically, pNIPAM 
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microgels synthesized in the absence of exogenous crosslinker termed ultra low 
crosslinked (ULC) microgels were studied, in addition to those synthesized with 2% 
methylene-bisacrylamide (BIS) crosslinked microgels. In order to compare results 
between the two types of microgels, measurements of microgel suspension viscosity were 
necessary to calculate the volume fraction of microgels at certain concentrations to 
control this parameter when forming composite fibrin-microgel constructs. Furthermore, 
structural and mechanical properties of the composite materials were measured and 
analyzed to understand the composition and behavior of the system. Computational 
analysis of reconstructions of the three-dimensional structures further allowed for an 
understanding of the architecture of the materials and quantitative measures of relative 
volume fractions, network sizes, and connectivity of microgel domains. These findings 
facilitated the understanding of the system for generation of future hypotheses with 
respect to how cells will interrogate and interact with these composite materials. 
3.2 Materials and Methods 
3.2.1 Microgel synthesis  
 Ultra low crosslinked microgels of poly(N’isopropylacrylamide-co-acrylic acid) 
(95%pNIPAM/5%AAc) were synthesized from standard precipitation polymerization 
techniques as previously described [24, 172, 173, 180]. Briefly, sterile filtered solutions 
of NIPAm monomer (recrystallized from n-hexanes) and acrylic acid were mixed at 450 
rpm in a reaction vessel at 70 °C before the addition of an initiator, ammonium persulfate 
(APS). For BIS crosslinked microgels, 2% bisacrylamide was added to the reaction as an 
exogenous crosslinker to produce more highly crosslinked, and thus stiffer particles. In 
both cases, the reaction proceeded for 6 hours, after which the solution of microgels was 
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cooled, filtered through glass wool, and purified by ultra-centrifugation. Purified 
microgels were lyophilized for future use. Fluorescent microgels were generated through 
labeling of AAc groups with cadaverine conjugates of AlexaFluor dyes (cadaverine 
AF488, 555,647, Life Technologies) via EDC/NHS chemistry. ULC microgels were 
resuspended in 25 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 150 
mM NaCl pH 7.4 (HEPES buffer) at stock volume fractions of either 0.28 or 0.56 (10 or 
20 mg/mL for ULC) for future experiments. 
3.2.2 Microgel characterization with static and dynamic light scattering 
3.2.2.1 Multiangle static light-scattering5 
 Multiangle static light-scattering (3DDLS-Pro Spectrometer) was performed by 
collaborators in the Fernandez-Nieves groups. To compare to previous findings, a 90° 
setup for dynamic light scattering was additionally executed. To perform the static and 
dynamic light scattering measurements (SLS and DLS, respectively) for 5% AAc ULC 
and 2% BIS crosslinked particles, we used a 3D cross-correlation (for removing multiple-
scattering) setup (LS Instruments). The 3D DLS system allowed for removal of multiple 
scattering from the data, enabled the measurement of Rg (in addition to Rh), and also 
allowed for more precise fit of the form factor to different model functions, which gave 
information about the radial distribution of polymer density in the particles. Laser light 
incident onto the sample was scattered into a detector that was positioned at different 
angles to the incident beam. Different angles correspond to different momentum changes 
q of the scattered light, according to q = 4πn
λ0
sin(θ / 2) , where λ0 is the wavelength of the 
                                                
5 Portions adapted from Bachman et al. Ultrasoft, highly deformable microgels, Soft Matter, 11 (2015) 
2018-2028. Adapted from with permission by The Royal Society of Chemistry. 
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light in vacuum and n is the solvent refractive index.  In SLS, the average intensity 
scattered into a particular q is analyzed to provide information about the internal structure 
of the particles.  In our case, the accessible q-range included the Guinier regime, in which 
the intensity decays according to e−(qRg )
2/3
, where Rg is the particles' radius of gyration, 










  [225]. By fitting this to the observed low-q intensity, we 
obtained Rg values for our particles at different conditions.  If instead of averaging, the 
time-dependent intensity fluctuations are cross-correlated, we obtained the electric field 
cross-correlation function, defined as g! τ ∝ e-­‐!!!!, [226] where τ is the correlation lag time 
and D is the particles' diffusion coefficient.  The hydrodynamic radius of our particles 
was given by the Stokes-Einstein equation, R! = k!T/6πηD, where kB   is the Boltzmann 
constant, T is the temperature in Kelvin, and η is the solvent viscosity [225].  The ratio 
Rg/Rh is a measure of the mass distribution inside the particles.  For a sphere with 
homogeneous density, Rg/Rh has the analytical value 3 / 5 ; for a particle with mass 
concentrated at the center, such as a core-shell particle, this value is lower, while for a 
particle with mass concentrated at the outside, such as a hollow sphere, this value is 
higher.  We measured Rg and Rh for our particles over a range of temperatures both above 
and below the pNIPAm LCST of ~33 °C in pH 7.4 HEPES buffer.  Note that although 
the acrylic acid co-monomer is ionized at this pH, which should increase the LCST [227], 
its low concentration in the microgels (5%) and screening by the dissolved salt ions 
minimized any such LCST perturbation.   
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3.2.3 Viscometric measurements of dilute microgel suspensions6 
	   Since the particle volume fraction, Φ, is the relevant measure of concentration in 
colloidal suspensions, viscometry was performed to determine this quantity for both ULC 
and BIS crosslinked µgel suspensions. An Ubbelodhe viscometer was used to measure 
the time it takes for dilute suspensions of various microgel weight percentages to travel 
through a capillary. Temperature was controlled by immersing the viscometer in a water 
bath for the duration of the measurements. The time read out, constant for the viscometer, 
and density of the solvent was used to calculate the dynamic viscosity of the suspensions.  
The data were fit to the Einstein-Batchelor equation (η/η0 = 5.9Φ2+2.5Φ+1) and plotted 
as the ratio of dynamic viscosity measured to that of the solvent, η/η0, vs. the microgel 
weight percent (Figure 1C), to solve for Φ [228]. We note that Φ is proportional to the 
microgel concentration c, Φ = k * c, where the constant k can depend on pH, salt 
concentration and temperature, for a given microgel, since these variables can potentially 
affect the particle size. The variables k and η can also be used to understand how the 
solvent quality affects the solvation/swelling of the particles.  
3.2.4 Determination of effects of microgels on fibrin gel formation 
3.2.4.1 Fibrin and composite gel formation 
 Human fibrinogen (CSL Behring) was used to form fibrin gels. All gels were 
formed in HEPES CaCl2 buffer (150 mM NaCl, 5 mM CaCl2, 25 mM HEPES; pH 7.4) 
and thrombin (0.1-10 U/mL). Composite gels were formed through mixing of ULC 
microgels with the fibrinogen/HEPES/CaCl2 mixture prior to the addition of thrombin 
                                                
6 Portions adapted from Bachman et al. Ultrasoft, highly deformable microgels, Soft Matter, 11 (2015) 
2018-2028. Adapted from with permission by The Royal Society of Chemistry. 
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(0.1, 1, or 10 U/mL). Clots were allowed to polymerize for 1 hour prior to imaging or 
other experiments.  
3.2.5 Mechanical measurements of fibrin-microgel composites 
3.2.5.1 Rheological measurements of composite gels 
 In order to study construct mechanics, a Physica MCR 501 cone and plate 
rheometer (Anton-Paar) was used (2.014° cone angle, and 24.960 mm tool diameter) to 
measure the viscoelastic properties of fibrin clots. Clots were formulated as described 
previously. Both frequency (0.01Hz-10Hz measuring 6pts/decade, 0.5% constant strain) 
and strain sweeps (0.1-100% strain measuring 6pts/decade, 1Hz constant frequency) were 
performed to record the storage (G’) and loss modulus (G”) of at least 6 gels from each 
group.  
3.2.5.2 Statisical Analysis 
 Statistical analyses were performed in GraphPad Prism (GraphPad Software, San 
Diego, CA). Differences storage moduli between groups measured were analyzed using a 
ordinary one-way ANOVA with a Tukey’s multiple comparison post-test. 
3.2.6 Fluorescence confocal microscopy of hybrid gels 
 Clots with and without Microgels were formulated as described above and 
polymerized for one hour between a glass slide and no.1 coverslip [72, 73]. Laser 
scanning confocal microscopy (LSM 700, Carl Zeiss, Inc.) with a 63X oil immersion 
objective (NA, 1.4) was used to visualize fibrin matrices using 5% AlexaFluor 647-
labeled fibrinogen and AF555 or AF488-microgels. Gels were imaged at least 25 µm 
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above the glass interface to avoid heterogeneities in the network near contact with the 
glass surface. 
3.2.7 Three-dimensional computational analysis of network architecture of fibrin-
microgel composites 
 3D confocal images were imported into MATLAB for custom processing and 
analysis. Using a custom in house built script, images were thresholded using the Otsu 
method, binarized, and run through a median filter. Next, the skeleton of the structure 
was obtained, which consisted of a central line having the same topology, branching, and 
overall shape of the initial structure. The skeleton was calculated by solving the eikonal 
equation and detecting all its singularities, which form a set that correspond to the seek 
skeleton [229]. The eikonal equation was solved using the fast marching method, which 
gave very accurate results in Cartesian coordinates [230].  From there the arc length of 
the skeleton was extracted and the connectivity of the sample was quantified. In 
particular, the number and location of the branches within the skeleton, as well as the 
branching number of every branch point and the average distance between branches was 
calculated. 
3.3 Results 
3.3.1 Microgel size and viscosity characterization 
ULC microgels were synthesized from pNIPAm and 5% AAc.  The size and 
viscosity of ULC particles or 2% BIS crosslinked pNIPAm microgels (also containing 
5% AAc) were analyzed through dynamic and static light scattering (DLS/SLS) and 
viscometry. These techniques were utilized to gain a thorough understanding of ULC size 
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and polymer distribution. The hydrodynamic radius is a measure of entire particle radius 
that can be obtained from the Stokes-Einstein equation, Rh = (kB T)/(6 π η D). Their 
results are comparable to previous findings and demonstrated a particle diameter of 
approximately 1 µm for the ULC microgels. More specifically, at physiological 
conditions, ULC and 2% BIS particles were found to have similar hydrodynamic radii 
and radii of gyration of 562 ± 8 nm/445 ± 5 nm and 382 ± 6 nm/313 ± 9 nm, respectively. 
Measurements were acquired in 25 mM HEPES 150 mM NaCl pH 7.4 at various 
temperatures, and little temperature dependence in radius was observed (Figure 2).  
 
Figure 2:  Hydrodynamic radius (Rh) and radius of gryration (Rg) of ULC and BIS 
microgels under physiological conditions. Dilute suspensions of microgels in 25 mM 
HEPES 150 mM NaCl pH 7.4 were analyzed using light scattering and their radii as 
a function of temperature are reported, ULC (in red) and BIS (in black).  
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 Typically, as pNIPAM is a thermoresponsive polymer with a volume phase 
transition temperature (VPTT) around 31-33°C, one would expect to see a collapse of the 
particle structure across this temperature regime. However, the microgels contain 5% 
acrylic acid, which is deprotonated at physiological pH. Additionally, the presence of 
NaCl at relatively high concentrations effectively deswells the microgel even at 
temperatures below the VPTT, when comparing Rh of the microgels in water. In order to 
gain an understanding of the microgel structure, a plot of Rg/Rh versus temperature was 
generated (Figure 3).  
 The radius of gyration is the root mean squared distance between monomers 
within a polymer, and it gives a measure of particle internal structure. The ratio of radius 
of gyration to hydrodynamic radius is a measure often used to understand a particles 
structure (homogenous sphere versus core-shell, etc.). Despite the low density of the 
ULC microgels, they approximate homogenous spheres well with data points clustering 
around a value of 0.77 or 3 / 5  (theoretical value for homogenous sphere, dotted line in 
Figure 3) with a slight increase in core versus outer density at lower temperatures (lower 
Rg/Rh), and a bump near the transition temperature.  This indicates that most of the 
particles' mass migrates to the particle periphery before homogenizing throughout the 
particle. It is important to note that while it can be assumed multiple scattering is not 
present in sufficiently dilute samples, there's an important exception that was meaningful 
for these measurements. Depending on the form factor, there can be minima in the 
angular scattering intensity.  This is particularly true of the homogeneous sphere case, 
where the minima are very sharp.  Even for a dilute sample, where multiple scattering is 
negligible at most angles, a significant portion of the intensity at these minima is 
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multiple-scattered.  This is true no matter how dilute the sample is, and can be proved (in 
3D cross-correlation measurements) by looking at the intercept as a function of 
angle:  there are minima in the intercept that correspond to those of the form 
factor.  Using the 3DDLS we were able to correct the form factor for this multiple 
scattering.  Without the correction, the minima will appear considerably less sharp, and 
the result would be that we would not have seen such a good fit to the homogeneous 
sphere form factor, and could have been led to believe that it was more of a core-shell 
morphology.   
 
Figure 3:  Ratio of radius of gryration (Rg) to the hydrodynamic radius (Rh) for 
ULC and BIS microgels under physiological conditions. Dilute suspensions of 
microgels in 25 mM HEPES 150 mM NaCl pH 7.4 were analyzed using ligh 
scattering. The dotted line represents the theoretical value for a homogenous sphere. 
Reproduced by permission of the Royal Society of Chemistry from [180]. 
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On average the BIS microgels Rg/Rh values are slightly lower, thus indicating a 
slightly more core-shell based structure, but overall these particles can be viewed as 
largely having relatively constant mass distribution throughout the particle structure.  
3.3.2 Determination of microgel volume fraction from mass concentration 
 In many cases, specific properties of suspensions of microgels are dependent on 
the effective volume fraction occupied by the dispersed component. Volume fraction can 
also serve as a unifying measure to understand the concentration and phase behavior of a 
suspension. Thus, we performed viscometric measurements to determine this quantity for 
both ULC and 2% BIS crosslinked microgel suspensions. Viscometric data (Figure 4) 
were fit using the Einstein-Batchelor equation.  
 
Figure 4:  Viscosity of microgel suspensions at various concentrations at 
physiologial conditions. The viscosity of dilute suspensions of microgels in 25 mM 
HEPES 150 mM NaCl pH 7.4 were measured using viscometry. Samples were tested 
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at 25° C or 37° C. Reproduced by permission of the Royal Society of Chemistry 
from [180]. 
 
 From these data, k values were calculated to allow conversion between 
concentration and volume fraction.  It was found that the lowest concentrations of 
microgels tested deviated systematically from the quadratic fit, which likely represents 
the sensitivity limits of the viscometer. The fit was constrained to go to one at zero 
volume fraction, and as a result we found that the deviations in fit at low microgel 
concentrations have negligible effects on the overall fit.  K-values for each of the ULC 
and BIS microgels at 25 °C or 37 °C were derived and are illustrated in Table 1 in the 
form of mL/mg.  
 
Table 1:  Viscometry K-Values (mL/mg) in 25 mM HEPES 150 mM NaCl pH 7.4. 
Microgel Type   25 °C   37 °C 
ULC 0.0388 0.0280 
BIS 0.0234 0.0171 
 
 Calculated k values were approximately 1.64 times higher for ULC microgels 
than 2% BIS crosslinked microgels of similar size. One way to conceptualize this is that 
1.64 times more BIS particles by mass must be utilized to reach equivalent volume 
fractions of ULC particles. This is another demonstration of the low density of these 
particles compared to more traditionally crosslinked microgels. 
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3.3.3 Rheological properties of fibrin gels with and without microgels 
 The properties of fibrin alone and composite gels were measured at both 8 and 25 
mg/mL fibrin concentrations with and without ULC or BIS microgels at ϕ=0.112.  
 
Figure 5:  Rheological properties of fibrin and hybrid fibrin-microgel constructs. 
Storage and loss moduli of gels were measured within the linear regime at 0.5% 
strain over a frequency range of 0.01 to 10 Hz.  Representative curves are shown for 
fibrin 8 mg/mL alone and fibrin 8 mg/mL with ϕ=0.112 ULC microgels. 
 
 Initially, a strain sweep at constant frequency of 1Hz was performed to determine 
the linear regime, as fibrin is known to be strain stiffening [231]. From this test, a strain 
of 0.5% was determined to be appropriate for subsequent tests. The frequency response 
was measured within the linear regime of G’G” of the 8 mg/mL fibrin gels with or 
without microgels, and found to be indistinguishable from one another. The behavior was 
typical of a viscoelastic solid. Data from 8 mg/mL fibrin samples with and without 
microgels at ϕ =0.112 is shown in Figure 5 and illustrates that microgels have no 
dramatic effect on the rheological properties of the fibrin composite gels. 













+ ULC (φ=0.112) G'
Fibrin G"
+ ULC (φ=0.112) G"
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Figure 6:  Storage modulus of fibrin and hybrid fibrin-microgel constructs.   
Storage and loss moduli of gels were measured within the linear regime at 0.5% 
strain over a frequency range of 0.01-10 Hz.  Statistics were measured using a 
Ordinary one-way ANOVA and Tukey’s multiple comparison test, bars represent 
mean ± standard deviation. While there are significant differences between all of the 
8 mg/mL and all 25 mg/mL groups (p<0.0001), there are no significant differences 
between no microgels, ULC, or BIS groups at either fibrin concentration. 
 
 The storage modulus of fibrin gels with and without microgels at various fibrin 
concentrations were measured and are displayed in Figure 6. G’ values were averaged 
across the frequency regime tested (0.01-10 Hz) for three individual gels per group (n=3). 
As expected, there were significant differences in the average storage moduli between the 











































































However, within each fibrin concentration, no significant differences were found between 
the groups with and without microgels. This demonstrated that the presence of the 
microgels did not affect shear rheological properties of the materials compared to fibrin 
alone. 
3.3.4 Visualization of hybrid fibrin-microgel composite gel structure 
 The gel structures were imaged using clots that were doped with 5% fluorescent 
fibrinogen in addition to fluorescently labeled microgels. Individual slices within the 3D 
volume are shown in Figure 7.  
 
Figure 7:  Confocal images of fibrin gels with and without ULC or BIS microgels.  
Single confocal slices of fibrin 8 mg/mL alone and fibrin 8 mg/mL with ϕ=0.112 
ULC microgels (labeled and unlabeled) (top row).  Fibrin 8 mg/mL with ϕ=0.112 
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BIS microgels, or ϕ=0.068 BIS microgels (labeled and unlabeled)   (bottom row), 
scale bar 20 µm. 
 
 In the fibrin alone clot, it can be appreciated that the fibrin mesh is dense and 
even difficult to distinguish pore size in these matrices. However, when microgels are 
added to the networks to form composite gels, spaces within the fibrin mesh are 
generated, which are filled with microgels that have clustered into multi-microgel 
domains, as opposed to remaining a homogenous dispersion of microgels in the polymer 
matrix. It is also of note that controlling volume fraction between the ULC and BIS 
microgels is the relevant parameter to control and that strikingly similar networks are 
formed irrespective of microgel crosslinking density. However, if microgel weight 
percent or mass based concentration is controlled, this results in different network 
structures due to the differences in mass and size of the ULC and BIS microgels. 
 
Figure 8:  Maximum intensity projection of interconnected microgel network 
formed in fibrin 8 mg/mL with a mixture of fluorescently labeled ULC microgels. 
Labeled with AF488 and AF555 (ϕ=0.112), scale bar 20 µm. 
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 Above, in Figure 8, a maximum intensity projection of the interconnected 
microgel network within the dense fibrin 8 mg/mL gel is shown. This image illustrates 
the packing and arrangement of microgels within the ‘tunnels’ that are formed in fibrin. 
3.3.5 Quantification of microgel network structure using MATLAB computational 
analysis of confocal images of fibrin-microgel composites 
 Confocal z-stacks of hybrid matrices were acquired for samples containing 8 
mg/mL fibrin with various concentrations of microgels (ϕ=0.028, 0.056, 0.112, 0.168). 
The stacks were analyzed with the MicrogelNetworkAnalysis m-file in matlab in order to 
process the image, generate a skeleton, and output variables of interest. From the 
skeletonized data, the number of connected volumes (or connected microgel domains) 
was calculated, with fewer networks indicating a larger degree of network connectivity. 
Additionally, the radius, length, and volume percent of these connected volumes was 
calculated, as additional characterization parameters. A schematic of the summarized 
process can be found in Figure 9. 
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Figure 9:  Network analysis process, 3D reconstruction, and skeletonization image 
processing.  Confocal z-stack of fluorecently labeleded fibrin 8 mg/mL with ϕ=0.112 
ULC microgels and 1.0 U/mL thrombin was analyzed. A) Initial image, B) image 
with overlaid found microgel spaces, C-D) 3D reconstruction/isosurface of microgel 
network, and E-F) found skeleton-tracing the centroid of the network are shown. 
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 Results from the network analysis described in Figure 9 of representative data is 
summarized in Table 2. Overall, it was observed that the radius of microgel domains 
averaged around 4.5 µm for this gel formulation. 
 
Table 2:  Network analysis results for fibrin 8 mg/mL with ULC microgels ϕ=0.112 











1 4.5 0.916 1.23 77 
2 3.41 0.017 0.034 1 
3 5.16 0.013 0.033 3 
4 4.1 0.009 0.011 1 
 
 
 Additionally, as initial microgel volume fraction was increased shown in Figure 
10, the microgel domains grew into interconnected networks. Clusters of microgels 
associated in pockets, which then eventually grew to a point to join with other pockets 
and form a percolating network throughout the 3D volume.  
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Figure 10:  ULC concentration modulation.  Confocal slices of fluorecently 
labeleded fibrin 8 mg/mL with increasing volume fractions of ULC microgels (left to 
right) at 1.0 U/mL thrombin. Initial images (top row), image with overlaid found 
microgel spaces (bottom row).  
 
 This interconnectivity is further illustrated by the decrease in number of detected 
connected volumes (converging towards 1) and increase in length and volume percent 
(reaching values in the 90+ % range) of the main connected volume with increasing 





Table 3:  Network analysis results for fibrin 8 mg/mL with ULC microgels ϕ=0.028 











1 4.32 0.090 0.206 19 
2 3.83 0.089 0.293 43 
3 3.62 0.071 0.158 15 
4 4.43 0.039 0.120 10 
5 4.25 0.015 0.0001 8 
+ 279 others     
 
Table 4:  Network analysis results for fibrin 8 mg/mL with ULC microgels ϕ=0.056 











1 3.31 0.045 0.112 11 
2 3.31 0.023 0.0548 2 
3 4.28 0.021 0.0534 4 
4 4.21 0.019 0.0408 5 
5 3.49 0.017 0.0466 4 
+ 264 others     
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Table 5:  Network analysis results for fibrin 8 mg/mL with ULC microgels ϕ=0.112 











1 4.5 0.916 1.2320 77 
2 3.41 0.017 0.0344 1 
3 5.16 0.013 0.0329 3 
4 4.1 0.010 0.0114 1 
5 4.02 0.009 0.0121 1 
+ 12 others     
 
Table 6:  Network analysis results for fibrin 8 mg/mL with ULC microgels ϕ=0.168 











1 4.36 0.998 1.2639  
2 4.62 0.0007 7.47E-03  
3 5.33 0.0007 4.91E-03  
4 3.95 0.0006 2.97E-03  
 
 Upon closer look of the data, there appears to be a switch somewhere between 
ϕ=0.056 and 0.112 where the network becomes percolated, i.e. individual domains begin 
to connect and grow to a point where there is a single path that can be followed 
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throughout the volume from one side to another (Figure 11).  Thus, it was determined 
that at a critical volume fraction of microgels, the network becomes interconnected and 
that value was found to be ϕc=0.112. 
 
 
Figure 11:  Demonstration of critical threshold of microgel volume fraction where 
network percolation occurs. Analysis of confocal data is summarized here for 
hybrid constructs. From left to right, volume percent of the main connected volume, 
arc length, and number of branches are shown for various volume fractions of 
microgels.   
3.4 Discussion 
 In this aim, microgels were characterized as well as the fibrin-microgel hybrid 
constructs utilizing a variety of imaging and mechanical methods. It was found that both 
the ULC and BIS microgels are approximately 1 µm in diameter and have a structure 
similar to that of a homogenous sphere. The microgels do not display strong temperature 
dependent swelling behavior due to the high concentration of salt under physiological 
conditions in addition to the presence of acrylic acid, which is deprotonated under 
physiological pH. Fibrin gels at 8 mg/mL form dense matrices and when microgels are 
incorporated into these clots, polymerization is not inhibited and clustered microgel 
domains are generated that grow into percolated networks with increasing initial microgel 



















































volume fraction. Additionally, similar 3D architectures were formed independent of 
microgel crosslinking density as long as volume fraction was controlled illustrating that 
this phenomenon is not necessarily microgel specific, but is dominated by fibrin 
polymerization in the absence of any known fibrin-microgel interactions. Interestingly, 
the presence of microgels does not affect the storage or loss moduli of the composite gels 
compared to fibrin only controls. This was hypothesized to be due to the maintenance of 
the characteristic length scale of the pore size, as G’ = kBT/ζ3. The microgels are 
maintained within fibrin and their size is on the same order as the fibrin mesh size, thus 
G’ is conserved. However, if the microgel networks were instead – empty voids, then the 
characteristic pore size of the composite network would increase, thus decreasing G’ 
(since they are inversely proportional). Additionally, because the microgels are 
maintained with the fibrin networks, as opposed to being cleared out like many porogen 
systems [89, 120], they are able to add a compressive strength to the matrices and hold 
water within their structure, as opposed to fibrin alone clots which collapse under 
significant applied force. Additionally, it should be noted that microgels display 
dramatically different rheological properties in shear when compared to those of a bulk 
gel. When a strain is applied to a suspension of microgels, they have the capability to 
rearrange their structure and organization around one another, unlike bulk gels where 
crosslinks inhibit relaxation. However, because the microgels are contained within the 
fibrin network, the rheological measurements that we acquired do not display these 
properties (likely because the fibrin pore dominates). From a cellular perspective, this 
could be a potentially useful characteristic within the tissue construct, because the 
mechanics of the construct are conserved; yet at the micro-scale, semi-fluid microgel 
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domains could possibly structurally rearrange and adjust with applied force or cellular 
interrogation. 
 Finally, there appears to be a critical initial microgel volume fraction, above 
which clustered microgel domains become connected to form an interconnected 
percolated network. This information allowed for a better understanding of the base 
system to allow a better understanding of how biological processes many potentially 
harness these composite materials for enhanced phenotypic outputs. 
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CHAPTER 4  DETERMINATION OF THE EFFECTS OF 
FIBRIN-MICROGEL HYBRID CONSTRUCTS ON CELLULAR 
PHENOTYPE 
4.1 Introduction 
 When designing a material for tissue engineering applications, one design criteria 
to consider is to match the mechanical properties of the implant material to the host tissue 
to promote recruitment and specification of host cells to facilitate repair or regeneration 
[32]. This design criterion is supported by the literature [232], which shows that material 
mechanical properties affect cell fate in vitro [233-236] and in vivo [235, 237, 238].  In 
seminal work from Discher and Engler, it was discovered that substrate elasticity directed 
mesenchymal stem cell phenotype through the cell’s ability to ‘mechanosense’ via the 
actin-myosin cytoskeleton and cell-matrix adhesions [233, 239]. More specifically, 
Engler observed when MSCs were plated on soft substrates, they differentiated towards a 
neurogenic lineage, on an intermediate stiffness they displayed myogenic markers, and 
on stiff substrates they displayed osteogenic characteristics [234]. Work from Helen 
Blau’s group has also demonstrated the effect of matrix elasticity on cell fate in vitro 
through rescuing muscle stem cell potency when culturing the cells on softer substrates 
mimicking muscle (12kPa) compared to tissue culture plastic (106 kPa) [236, 240]. 
Translating the 2D matrix elasticity findings to cell fate into 3D tissues using proteomic 
profiling, Swift et al. demonstrated that expression of the nuclear intermediate filament 
protein lamin-A changed in response to changes in tissue elasticity (increased expression 
with increasing stiffness). Thus cells can transduce mechanical signals through nuclear 
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lamin-A to enhance tissue-specific differentiation in vivo [238]. Additionally from a 
mechanics perspective, matching mechanical properties of an implanted material to that 
of the target tissue diminishes any differences in stress profiles that the tissue may 
experience during applied force. Fibrin matrices can be pre-formed and implanted at a 
site of injury, or polymerized in situ to fill a physiological site of interest. In the previous 
chapter, it was demonstrated fibrin mechanical properties could be tuned through 
alternation of fibrinogen concentration, but microgels do not have a significant effect on 
the shear modulus. Fibrin degradation products are pro-angiogenic [63, 64], making it 
suitable choice for the base polymer system. An engineering strategy was developed to 
overcome the shortcoming of utilizing fibrin gels with high fibrinogen concentrations, 
and a thorough characterization of the fibrin-microgel hybrid matrices was performed. 
Thus, this aim focuses on understanding the effect of these constructs on cellular 
phenotype when compared to fibrin only controls.  
 The engineering goal of these composite materials was to enable enhanced cell 
spreading and motility compared to dense fibrin only constructs that impeded these 
processes. Cellular morphological outputs, such as spreading, are prerequisites to 
enabling cell migration and thus cell infiltration, which ultimately leads to host-material 
integration [32].  The hypothesis of this aim was that the addition of microgels would 
allow for increased cell spreading, motility, and infiltration.  
4.2 Materials and Methods 
4.2.1 Cell culture 
 NIH 3T3 fibroblasts (ATCC) were cultured according to manufacturer’s 
recommendations and sub-culturing protocols in Dulbecco’s modified eagle’s medium 
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DMEM with 4.5 g/L glucose, L-glutamine, sodium pyruvate and supplemented with 1% 
penicillin/streptomycin and 10% bovine calf serum. 
4.2.2 Fibrin gel formation 
4.2.2.1 Preparation of fibrin gels with and without microgels 
 Gels were formed as described previously in Chapter 3. Human fibrinogen (CSL 
Behring) was used to form fibrin gels in HEPES (N-2-hydroxyethylpiperazine-N-2-
ethanesulfonic acid) CaCl2 buffer (150 mM NaCl, 5 mM CaCl2, 25 mM HEPES; pH 7.4). 
Composite gels were formed through mixing of ULC microgels with the 
fibrinogen/HEPES/CaCl2 mixture prior to the addition of thrombin (0.1, 1, or 10 U/mL). 
Clots were allowed to polymerize for 1 hour prior to imaging or the addition of media. 
When applicable, cell suspensions in culture media were added to the fibrinogen mixture 
prior to mixing with thrombin as 10% of the total clot volume. 
4.2.3 Cell spreading assay 
4.2.3.1 Experimental set-up and cell staining 
 For cell spreading assays, NIH 3T3 fibroblasts were incorporated into 
polymerizing fibrin only and fibrin-microgel gels in media at a density of 200,000 
cells/mL comprising 10% of the gel volume. Gels were formed as described previously 
with fibrin alone or fibrin with ULC microgels (ϕ=0.014, 0.028, 0.056, 0.112, or 0.168). 
After incubation over night, the samples were rinsed with cold 1X PBS, fixed with 4% 
formaldehyde (Sigma-Aldrich) for 20 minutes, permeabilized with 0.2% Triton X-100 for 
10 minutes, rinsed again with 1X PBS, and incubated with AF488 Phalloidin (Life 
Technologies) to stain the actin cytoskeleton and Hoechst 33258 (Life Technologies) to 
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stain the nucleus. Confocal z-stacks (100 µm) were imaged with a 10X objective and 
maximum intensity projections were created.  
4.2.3.2 Image acquisition and Quantification of cell morphology 
 Cell area was measured from maximum intensity projections using NIS Elements 
Software (Nikon) and other morphological parameters were calculated including 
circularity (=4*π*Area/Perimeter2) and elliptical factor (major/minor axis), which were 
measured from at least 50 different cells in 3 different gels. 
4.2.4 Cell motility assay 
4.2.4.1 Experimental set-up and cell labeling strategy 
 For motility studies, cells were stained with 10 µM of Cell Tracker Dye Green 
CMFDA (Invitrogen) for 15 minutes in growth media according to manufacturer’s 
instructions prior to encapsulation in gels. Cells were incorporated into polymerizing 
fibrin and fibrin-microgel gels in media at a density of 200,000 cells/mL comprising 10% 
of the gel volume. Two gels (fibrin +/- microgels, ϕ=0, 0.014, 0.028, 0.056, 0.112, or 
0.168, or BIS X-link microgels ϕ=0.112) per experiment were formed in a 35 mm dish 
side by side and were allowed to polymerize at 37C in the incubator for 1 hour prior to 
the addition of media on top of the composite gels. Cells were allowed to grow and 
spread overnight before beginning time-lapse experiments the next morning. Live cell 
imaging was performed with a Nikon BioStation IM-Q Live-Cell incubation chamber and 
microscope. Images of cells at least 25 µm above the interface were acquired with a 10X 
objective in phase-contrast and FITC every 10 minutes over the course of 12 hours in 6-
10 regions per gel from 2-3 independent experiments.  
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4.2.4.2 Image acquisition and Quantification of migration speed 
 Fluorescent images of labeled cells were imported into FIJI (ImageJ) and cells 
were manually tracked (recording x and y coordinates) over the duration of the 
experiment. Summed distance over time and average instantaneous speed was calculated 
for each cell over the course of the experiment and plotted. Dividing cells and cells that 
moved out of the viewing field for more than ½ of the experimental duration were 
neglected. At least 50-100 cells were tracked per experimental and control group from 2-
3 independent experiments. 
4.2.5 Cell infiltration assay 
4.2.5.1 Preparation of inner cell-laden fibrin gel 
 A dense cell laden gel was generated with 106 cells/mL in an 1 mg/mL fibrin gel 
according to fibrin gel formation protocols described previously. These gels were small 
volume (2ul) clots placed on the bottom of a 96 well plate and were polymerized for 15 
minutes prior to encapsulation with a second gel.  
4.2.5.2 Preparation of outer gel with or without microgels 
 After 15 minutes, the inner gel was then covered in a cell-free 8 mg/mL fibrin gel 
with or without microgels (ϕ=0.112). After allowing the second gel to polymerize for 1 
hour, cell culture media was added and the cells imaged with phase contrast microscopy 
at 4x magnification over the course of three days. 
4.2.5.3 Quantification of migration/infiltration distance 
 Infiltration/migration distance of the outgrowths into the surrounding gel from the 
core was measured from phase contrast images using ImageJ. Three random cell streams 
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migrating out from each gel were measured and averaged on each day, with data pooled 
from 9-12 gels per group over two independent experiments.  
4.2.5.4 Statisical Analysis 
 All statistical analyses were performed in GraphPad Prism (GraphPad Software, 
San Diego, CA). For cell morphology specifically, circularity– a one-way ANOVA was 
performed with a Tukey’s multiple comparisons post-test. For cell spread area and 
elongation, the data was not normally distributed and thus a Kruskal-Wallis non-
parametric test was used with Dunn’s post-test for multiple comparisons was performed. 
For analyzing cell infiltration in the outgrowth assay, a two-way ANOVA was performed 
with Bonferroni’s multiple comparisons test. For migration speed, the data did not fit a 
normal Gaussian distribution and thus the Kruskal-Wallis non-parametric test was used 
with Dunn’s post-test for multiple comparisons. Data is represented in box and whisker 
plots, which extend from the 25th to 75th percentiles with a line at the median and error 
bars to the minimum and maximum values. 
4.3 Results 
4.3.1 Cell morphological phenotype in fibrin-microgel composite gels 
 After overnight growth and spreading, cellular morphology and spreading in 
fibrin (8 mg/mL) constructs was examined, through visualization of the actin 
cytoskeleton as shown below in Figure 12.  
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Figure 12: Representative confocal maximum intensity projections of NIH3T3 
fibroblast morphology in fibrin-microgel constructs. Maximum intensity projections 
of staining of the actin cytoskeleton at various initial microgel volume fractions 
listed on the image are shown, scale 100 µm. 
 
In the fibrin alone groups, cells displayed a rounded morphology, as expected 
within these dense polymer scaffolds where cells must degrade the matrix around them in 
order to spread due to the small pore size of the network. However, when ULC microgels 
are incorporated into the network, a 1.85 fold increase in cell spreading is observed in a 
microgel concentration dependent manner (Figure 12, 13A). At the transition to a critical 
volume fraction ϕc the cell spread area jumps from an average of 728.5 µm2 in the fibrin 
only group to 1352 µm2 at ϕ = 0.112.  
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Figure 13: NIH3T3 fibroblast morphological analysis in hybrid fibrin-microgel 
constructs. Analysis of confocal data is summarized here for hybrid constructs. 
Average cell spread area measured from maximum intensity projections from 4 gels 















































































box and whiskers plot extends from the 25th to 75th percentiles with a line at the 
median and error bars to the minimum and maximum values, Kruskal-Wallis non-
parametric test was performed with Dunn’s post-test, **** p<0.0001 compared to 
ϕ=0 group;   B) Circularity analyzed, box and whiskers plot extends from the 25th 
to 75th percentiles with a line at the median and error bars to the minimum and 
maximum values, data passed normalcy test and one-way ANOVA with Tukey’s 
post-test for multiple comparisons was performed **** p<0.0001 compared to ϕ=0 
group. C) Elongation (min feret/max feret) was calculated and box and whiskers 
plot extends from the 25th to 75th percentiles with a line at the median and error 
bars to the minimum and maximum values, Kruskal-Wallis non-parametric test was 
performed with Dunn’s post-test, * p<0.01, **** p<0.0001 compared to ϕ=0 group. 
For all parameters n= 55-79 cells analyzed per volume fraction in a minimum of 3 
separate gels. 
 
 As the volume fraction of ULC microgels increases, cells lose their circularity 
becoming more elliptical and their overall spread area increases (Figure 13B,C). These 
findings demonstrate that the cells are able to leverage the microgel domains in order to 
extend protrusions and spread in three-dimensions. 
4.3.2 Cell motility in fibrin-microgel composite gels 
 In order to determine if these 3D interconnected microgel tunnels could affect 
cellular phenotype and motility in vitro, NIH3T3 fibroblasts were incorporated into the 
composite hydrogels during polymerization and were monitored over the course of 12 
hours after an initial 16 hours of growth and spreading. Time-lapse microscopy of 
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fluorescently labeled cells and manual tracking of random cell migration was performed 
on each of these constructs. Plotting migration distance versus time, cells were seen to 
follow a linear trend with increasing slopes for samples containing microgels compared 
to fibrin only controls (Figure 14), indicating steady and persistent random migration 
through the network.  
 
Figure 14: NIH3T3 fibroblast migration distance versus time in hybrid fibrin-
microgel constructs. Summed migration distance over the course of twelve hours is 
shown for a representative set of cells (n=10 per condition) for fibrin 8 mg/mL with 
and without ϕ=0.112 ULC microgels.  
 
 An increase in average migration speed was observed in a microgel dose-
dependent manner (Figure 15), for example an increase was observed from an average of 
1.78 µm/hr in a fibrin only control to 15.82 µm/hr with the addition of Φ=0.112 ULC 
microgels.  
 
























Figure 15: NIH3T3 fibroblast average migration speed in fibrin 8 mg/mL with 
increasing microgel volume fraction. Averge migration speed per cell is shown for 
fibrin 8 mg/mL with increasing volume fractions of microgels. Averages are 
calculated from the instantaneous speed of a cell over the course of the 12 hour 
experiment n = 2-4 gels (47-184 total cells analyzed per group). Box and whiskers 
plot extends from the 25th to 75th percentiles with a line at the median and error 
bars to the minimum and maximum values; Non-parametric Kruskal-Wallis test 
was performed with Dunn’s multiple comparisons test p<0.0001.   
 
 Increases in average migration speed through fibrin were also observed with the 
addition of equivalent volume fractions of BIS crosslinked microgels, but only reaching 
an average of 7.93 µm/hr, strongly suggesting that the deformability of ULC microgels 









































Figure 16: NIH3T3 fibroblast average migration speed in fibrin 8 mg/mL with and 
without microgels (ϕ=0.112). Average migration speeds are shown for cells 
polymerized in fibrin alone (gray), fibrin with BIS crosslinked (X-link) microgels 
(green) (n=51), or ULC microgels (purple) (n=184). Box and whiskers plot extends 
from the 25th to 75th percentiles with a line at the median and error bars to the 
minimum and maximum values; Kruskal-Wallis non-parametric test was 
performed with Dunn’s multiple comparisons test, **** p<0.0001. 
 
 This indicates a role for microgel composition, specifically deformability, in 
dictating cellular phenotype (both motility and morphology) within these composite 
materials. Additionally, at more clinically relevant fibrin concentrations of 25 mg/mL an 


































Figure 17: NIH3T3 fibroblast average migration speed in fibrin gels of various 
concentrations in comparison with those containing microgels (ϕ=0.112). Average 
migration speeds are shown for cells polymerized in fibrin alone, or various fibrin-
microgel hybrid constructs (n = 2-4 gels, 47-184 total cells analyzed per group). Box 
and whiskers plot extends from the 25th to 75th percentiles with a line at the median 
and error bars to the minimum and maximum values; Non-parametric Kruskal-






























































































 Additionally, cells within fibrin 8 mg/mL + ULC microgels ϕ=0.112 are able to 
migrate at significantly higher speeds than physiological controls of 2.5 or 4 mg/mL 
fibrin alone.  
4.3.3 Effect of microgels on cell infiltration in an outgrowth assay 
To look more specifically at infiltration, an in vitro outgrowth assay was 
performed to monitor migration of cells from a dense cell pellet into an outer fibrin gel 8 
mg/mL with or without microgels. Over the course of three days, significant migration 
(hundreds of microns) into the outer gel containing ULC microgels was observed 
compared to the fibrin only gel, which maintained a strict unchanged border as shown in 
Figure 18. Specifically, after 3 days, cells encapsulated by a fibrin only gel had only 
migrated on average 9.2 microns, whereas cells encapsulated by a hybrid gel containing 
microgels had migrated an average of 260.9 microns.  
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Figure 18: NIH3T3 fibroblast average migration speed in fibrin gels of various 
concentrations in comparison with those containing microgels (ϕ=0.112). Average 
migration speeds are shown for cells polymerized in fibrin alone, or various fibrin-
microgel hybrid constructs. Box and whiskers plot shown, migration distance 
averaged from 5 measurements from n=12 gels from two independent biological 
replicates (represented as median with 75/25% percentile with minimum and 
maximum).  A two-way ANOVA with Bonferroni’s multiple comparisons test was 
performed and statistically significant differences were found between ± microgels 
(p<0.0001) at each time point. 
4.4 Discussion 
 In this aim, it was observed that microgels enabled cell spreading, motility, and 


























occur at a similar initial volume fraction where the formation of an interconnected 
percolated network would be observed, around ϕc. This observation mirrors generally 
accepted engineering strategies from the literature where a highly interconnected network 
is known that to facilitate tissue integration and cell infiltration [13]. However, the 
microgels are maintained within the composite structure raising interesting questions for 
future studies about how the cells may be leveraging the microgel networks for enhanced 
motility. 
 With respect to cell migration speed measurements, it was observed that 
microgels were able to enhance average speeds to values above those found at 
physiological fibrin concentrations and even those at half the fibrin concentration of the 
composite gel. The incorporation of microgels (ϕ=0.112) to even higher concentration 
fibrin gels (25 mg/mL) was able to rescue migration speed to levels commensurate with 
physiological fibrin concentrations. It should be noted that all of these experiments were 
performed in the absence of a protease inhibitor, in order to more closely mimic the in 
vivo microenvironment. Therefore, some degradation is likely occurring and enabling 
migration. When the protease inhibitor aprotinin is added to the gels and media solutions, 
as commonly performed with fibrin in vitro cell culture assays [7], the presence of 
microgels still enables motility to degrees significantly greater than fibrin alone. 
However, the increase in migration speed is muted compared to data where no protease 
inhibitor is applied. Thus, microgels may enable degradation independent spreading and 
motility; however, their effect is more dramatic when degradation can proceed normally. 
 While the specific cellular mechanism is not well understood, the hypothesis is 
that somehow, the cell is able to harness the microgel-filled space to extend protrusions 
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and bind to fibrin at more distant locations from the cell body. Subsequently, the cell is 
able to generate more contractile forces as it is more spread. This could be through 
enhanced local deformation surrounding the individual cell. While it is unlikely that the 
presence of microgels alone upregulates the expression of proteolytic enzymes by the 
encapsulated cells, there is evidence in the literature, that cell spreading/contractility and 
MMP expression are linked [241]. Thus, cells with increased contractility that are able to 
extend protrusions (in the cancer field, termed invadopodia) increase their proteolytic 
activity and have enhanced expression of MMPs [242].  
 Additionally, cells could be harnessing the microgel suspension characteristic 
relaxation time in order to extend protrusions through the microgel-filled domains within 
the composite gel. This hypothesis could be compared to the analogy of a child playing in 
a ball pit at a playground with a fixed volume. If one were stuck in a packed suspension 
of balls, the ability for motion to occur would depend on the ball pit packing fraction, the 
deformability of the balls, and the ability of the balls to move/rearrange with respect to 
one another. Evidence from this aim suggests that particle crosslinking density (i.e. ULC 
microgels compared to BIS microgels) affects migration speed of NIH 3T3s in these 
composite gel systems. Thus, microgel deformability or microgel relaxation time 
(rearrangement time) could be a logical mechanism that the cells are utilizing to move 
through these composite materials.  
 As a final hypothesis, cells theoretically could be phagocytosing microgels and 
effectively ‘eating’ their way through the composite matrix. This hypothesis is difficult to 
test due to the inability to image microgels in their native unmodified chemical form 
(since fluorescently labeling the particle occupies the acrylic acid site and thus may 
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change the net charge of the particle). Individual unmodified microgel particles of this 
size cannot be visualized in phase contrast or DIC under high magnification unless they 
are present at high volume fractions in a microgel suspension. Cellular detail likely 
prevalent due to the structure of organelles within the cell body made it impossible to 
discern differences in the internal structure (i.e. whether microgels were present) in cells 
incubated in hybrid constructs. Literature in the phagocytosis of particles is quite rich, 
and it has been shown that negatively charged unmodified particles are typically not 
internalized by cells [243-246]. Flow cytometry experiments of cells incubated in fibrin-
microgel composite gels, which were then digested to release the encapsulated cells, 
showed no observable differences in forward scatter or side scatter (data not shown). 
Large concentrations of fluorescently labeled microgels were incubated with cells in 2D 
culture and no particles were visualized within the cells after 4 hours (data not shown). 
However, when imaging cells embedded in hybrid matrices with fluorescently labeled 
microgels, microgels appeared to co-localize with the cell body. As large amounts of 
microgels are present, the delineation of microgels inside versus outside the cell is 
difficult to appreciate. Additionally, it is unclear if this is an artifact of the chemical 
modification of these specific microgels for fluorescent confocal microscopy 
visualization experiments. Consequently, experimental confirmation of this hypothesis 
has been a challenge and the results are unclear, but may be suggestive of another 
mechanism cells could use to navigate in confined tissue spaces in the presence of 
molecular crowding.  
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CHAPTER 5  INVESTIGATION OF THE MECHANISM OF 
MICROGEL NETWORK FORMATION IN FIBRIN AND OTHER 
MATERIALS 
5.1 Introduction 
 Why do microgels cluster into interconnected domains in fibrin materials? Upon 
polymerization, what drives the microgels into these networks as opposed to remaining 
homogenously dispersed within the gel? In efforts to better understand how these 
interconnected composite materials are formed and what dictates their structure, this 
chapter focuses on investigating the mechanism of microgel network formation. This is 
important because if we understand how the system is functioning in the example of 
fibrin, then potentially we can translate our findings to other biomaterial systems. This 
could enable significant benefits in material systems that suffer from the drawbacks of 
small pore sizes (which includes many synthetic materials). Using fibrin as a model 
system where the reaction kinetics can be tuned by adjusting the concentration of the 
catalytic enzyme, thrombin, we studied how these composite materials form and the 
factors that dictate their resulting architecture. The hypothesis of this sub-aim was that 
the size and shape of microgel networks within fibrin would be dictated by the 
polymerization rate of fibrin.  
 Based on evidence in the hybrid-fibrin microgel system, it was hypothesized that 
the architecture of the resulting microgel network structure was connected to the method 
of gel polymerization or crosslinking. This was investigated in fibrin by modulating 
thrombin concentration and observing polymerization in real-time. To further test the 
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hypothesis that polymerization or gel crosslinking method would determine the resulting 
microgel network architecture, experiments were performed with PEG gels as well as 
Alginate. PEG hydrogels can be formed using different gelation strategies, and in this 
work UV free radical polymerization of PEG diacrylate and Michael-type addition of 
PEG-maleimide were explored [247]. Alginate, an anionic polysaccharide derived from 
brown seaweed, was also tested as it has frequently been studied as a tissue engineering 
scaffold or synthetic ECM material [248]. Alginate gels crosslink through alternative 
mechanism known as ionic crosslinking [249]. Thus, when alginate molecules are 
exposed to divalent cations such as Ca2+, the gel structure becomes crosslinked [250]. 
These reactions important to materials such as PEG and alginate represent a 
fundamentally different method of polymerization or crosslinking when compared to 
materials like fibrin. Through this study, the mechanisms of microgel network formation 
were explored to allow for a better understanding of the system and facilitate translation 
of this technology into other materials. 
5.2 Materials and Methods 
5.2.1 Composite gel formation with thrombin modulation  
5.2.1.1 Preparation of composite gels with varying thrombin concentrations 
 Fibrinogen (CSL Behring) purified from human plasma (containing FXIII and 
fibronectin) was used at various concentrations throughout the study. For the formation 
of fibrin clots, fibrinogen was mixed with 25 mM HEPES 150 mM NaCl (HEPES buffer) 
pH 7.4, and 5 mM CaCl2 prior to the addition of thrombin (0.1, 1, or 10 U/mL). 
Composite gels were formed through mixing of ULC microgels with the 
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fibrinogen/HEPES/CaCl2 mixture prior to the addition of thrombin (0.1, 1, or 10 U/mL). 
Clots were allowed to polymerize for 1 hour prior to imaging. 
5.2.1.2 Rheological measurements of composite gels with varying thrombin 
concentrations 
 In order to measure the gel point of the hybrid matrices, a time sweep was 
performed after the addition of thrombin to the composite fibrin-microgel suspension. 
Measurements were acquired at a fixed strain of 0.5% every second, and G’, G” were 
recorded for 3 independent gels. The gel point was calculated as the total time required 
after initiation of polymerization at which G’ became greater than G”. 
5.2.1.3 Real time polymerization of composite gels imaged with spinning-disk 
fluorescence confocal microscopy 
 A Cell Observer Spinning Disk (SD) confocal (Carl Zeiss Microscopy Ltd) was 
used for the acquisition of time-lapse videos of real time microgel network formation in 
3D composite gels with varying thrombin concentrations. Gels were formed as previously 
described using AF488 fluorescently labeled ULC microgels. Briefly, fibrinogen (8 
mg/mL) and ULC microgel (ϕ=0.112) solutions were pipetted onto the glass bottom dish 
for initial visualization of microgels in the fluid suspension and adjustment of the focal 
plane. Thrombin was then added to the mixture at the desired concentration and 
measurements were recorded immediately after mixing. Images were acquired at the 
fastest frame rate possible through the three dimensional volume. Using a 63 X (plan 
Apochromat NA 1.46) objective, the optimal sampling for 25 µm thick stacks gave 
images every 0.25 microns resulting in 100 images per stack. Acquisition proceeded 
continuously until the system halted and appeared to reach a gelled equilibrium state.  
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5.2.1.4 Three-dimensional computational analysis of network architecture with 
modulation of thrombin concentration 
 Composite gels with fluorescently labeled fibrinogen were prepared as described 
previously, but were polymerized with varying concentrations of thrombin, either 0.1, 
1.0, or 10 U/mL. Confocal z-stacks were acquired as previously described (in Chapter 3) 
using a 63X objective and MATLAB image processing was performed. The custom 
network analysis script described in Chapter 3 was then additionally utilized to measure 
the architectural parameters of the microgel networks, as described previously. 
5.2.1.5 Cell motility experiments in composite gels with varying thrombin conentrations 
 Composite gels containing NIH3T3s were polymerized as described previously, 
but with 0.1, 1.0, or 10 U/mL thrombin. Similarly as outlined in Chapter 4, cells were 
tracked over the course of 12 hours and migration speed was quantified.  
5.2.2 PEG-microgel composite gel formation 
 First, free radical polymerization of PEG diacrylate (PEGDA) was performed 
using Igracure 2959. Briefly, PEGDA (Mw = 2500 Da) was dissolved in PBS at a final 
concentration of 10 wt %. AF488 ULC microgels at a final concentration of ϕ = 0.112 
were added to the PEG mixture, followed by the addition of I2959 at a final concentration 
of 0.05 wt%. The solution was mixed and pipetted onto a glass bottom dish and 
polymerized under UV exposure at 10 W/cm2 for 10 minutes. The microgels within the 
resulting gel was then imaged using confocal microscopy. 
 As another example, PEG-4MAL [247] was generously obtained from the García 
Lab and utilized for composite PEG-ULC microgel composites. In these materials, PEG-
4MAL (Mw = 20 kD) was utilized and resuspended in PBS for a final concentration of 
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4%. AF488 ULC microgels were added at a final concentration of ϕ = 0.112 in 25 mM 
HEPES 150 mM NaCl, which would additionally facilitate the addition reaction as 
HEPES is a nucleophilic buffering reagent. The peptide cysteine reactive peptide 
crosslinker GDQ was added at a 1.45:1 molar ratio of crosslinking peptide to PEG at 
physiological pH. Crosslinking was initiated for the formation of a gel and 
immobilization of microgels within the PEG structure was visualized within a few 
minutes. For later depletion experiments, PEG-4MAL was resuspended at 100 mg/mL as 
a stock solution in PBS and added at varying concentrations to microgel suspensions. 
5.2.3 Alginate-microgel composite gel formation 
5.2.3.1 Alginate source and characterization 
 Sterile irradiated alginate generously obtained from the Guldberg Lab sourced 
from FMC Biopolymer (FMC Biopolymer, Sandvika, Norway) with a high G to M ratio 
was utilized [251, 252]. It was resuspended at a concentration of 5 wt% in alpha-MEM 
for composite gel formation experiments. Cross-linking of alginate can be achieved 
through the addition of divalent cations to the polymer in solution, specifically, calcium 
(and calcium sulfate was used in these studies). AF488 Microgels (ϕ=0.112) were mixed 
with the alginate solution reaching a final concentration of 1% alginate and a final 
concentration of 6 mM CaSO4 was added to induce crosslinking.  
5.2.3.2 Composite alginate-microgel confocal imaging 
 Confocal imaging of the 3D alginate composite gels with fluorescently labeled 
ULC microgels indicated that crosslinking had occurred and microgels were 
immobilized. In order to determine the mechanism of clustering in alginate, AF488 
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labeled microgels in HEPES buffer were pipetted on the LSM 700 fluorescent confocal 
microscope (Carl Zeiss Microscopy, Ltd) for continuous real time imaging with a 60X 
objective. Alginate alone was added to the solution of microgels at different 
concentrations to determine if depletion induced pre-clustering was occurring prior to the 
addition of CaSO4. 
5.3 Results 
5.3.1 Effect of modulating thrombin concentration on composite gel formation 
 To determine the mechanism of formation of these microgel assemblies, we 
performed and imaged polymerization in real-time using fibrinogen (8 mg/mL) and 
fluorescently labeled ULC microgels (ϕ=0.112) to observe assembly. We observed that 
the ULC microgels were homogenously dispersed prior to polymerization and were 
driven to form packed interconnected networks with the addition of thrombin. 
Representative images at the endpoint of the experiment of the gels formed with different 
thrombin concentrations are shown in Figure 19. 
 
 
Figure 19: Incorporation of fluorecently labeled microgels (ϕ=0.112) in fibrin 8 
mg/mL polymerized with varying concentrations of thrombin. Maximum intensity 
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projections of fibrin gels with AF488 ULC microgels polymerized with either 0.1, 
1.0, or 10 U/mL thrombin. 
 
 When polymerizing a fibrin gel, it is known that changing thrombin concentration 
affects the polymerization rate [72, 81] and thus changes the gel point of the material. 
This was confirmed in Figure 20, where it is shown that increasing thrombin 
concentration decreases the time for G’ to overcome G”, the transition point for the 
material where it becomes more solid-like than fluid-like.   
 
Figure 20: Rheological measurement of gel point of hybrid fibrin-microgel 
constructs with varying concentrations of thrombin. G’,G” of polymerizing gels was 
measured immediately after the addition of thrombin every second at 0.5% strain. 
Gel point was calculated as the time (seconds) at which G’ became > G”.  
 
 Analysis (similar as described in Chapter 3) of composite networks formed with 
fluorescently labeled fibrinogen 8 mg/mL and ULC microgels (ϕ=0.112) at various 
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volume percent of the main connected volume. It was observed that the average radius of 
these domains could be modulated through changing thrombin concentration (Figure 
21A) while the connectivity is maintained (Figure 21B).  
 
Figure 21: Network analysis of 3D hybrid fibrin-microgel networks polymerized 
with varying concentrations of thrombin. Confocal z-stacks of gels polymerized with 
fluorescently labeled fibrinogen were analyzed. A) Demonstrates the change in 
average microgel network radius with increasing thrombin concentration. B) Shows 
the volume percent of the main connected volume for increasing thrombin 
concentrations.  
 
 Details of the network analysis data for representative composite gels (fibrin 8 
mg/mL + ULC microgels ϕ=0.112) formed at various thrombin concentrations (0.1, 1.0, 




Table 7:  Network analysis results for thrombin modulation of fibrin 8 mg/mL with 












1 5.23 0.976 1.327 82 
2 4.36 0.013 0.029 2 
3 3.94 0.003 0.007 1 
4 1.23 0.002 0.008 1 
5 4.92 0.001 0.004 1 
+ 5 more     
  
Table 8:  Network analysis results for thrombin modulation of fibrin 8 mg/mL with 











1 4.5 0.916 1.2320 77 
2 3.41 0.017 0.0344 1 
3 5.16 0.013 0.0329 3 
4 4.1 0.010 0.0114 1 
5 4.02 0.009 0.0121 1 
+ 12 others     
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Table 9:  Network analysis results for thrombin modulation of fibrin 8 mg/mL with 












1 3.47 0.9983 2.4 187 
2 3.2 0.0008 0.0037 1 
3 6.23 0.0005 0.0082 2 
4 5.18 0.0004 0.0023 1 
 
 It is observed that the percent volume occupied by the main connected volume is 
consistently > 90% indicating that all formulations form interconnected microgel 
networks.  Additionally, the average radius for the main detected volume of each 
condition (0.1, 1.0, 10 U/mL thrombin) decreases from 5.23 µm to 4.5 µm to 3.47 µm, 
respectively. Because lower thrombin concentrations resulted in the formation of larger 
clustered microgel assemblies, the data suggest that the assembly results from the 
polymerization dynamics. The polymerizing fibrin represents multiple growing and 
branching rigid rod-like structures, which drive the microgels into confined 
domains/percolating networks.  The particles are being forced into a smaller volume as 
fibrin is formed. The microgels then adopt a structure within the composite, which is 
dictated by concentration and the strength/length scale of the particle-particle repulsive 
forces. 
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5.3.2 Effect of fibrin-microgel network architecture on cell motility 
 Migration speed was analyzed as described previously and results from fibrin 8 
mg/mL gels with ULC microgels ϕ=0.112 polymerized with either 0.1, 1.0, or 10 U/mL 
thrombin. In the 0.1 U/mL thrombin group, slow polymerization of the hybrid gels 
resulted in settling of cells to the gel-culture dish interface, and thus these materials could 
not be analyzed. Results from 1.0 and 10 U/mL thrombin samples are displayed below in 
Figure 22.  
 
 
Figure 22: Comparison of migration speed of NIH3T3s in hybrid fibrin-microgel 
networks polymerized with varying concentrations of thrombin.  Averge migration 
speed per cell is shown for fibrin 8 mg/mL only, or fibrin 8 mg/mL with ϕ=0.112 
ULC microgels polymerized with 1.0 U/mL thrombin (n=4 independent 
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U/mL thrombin (n=1 independent experiment). Points represent average migration 
speed calculated from the instantaneous speed of a cell over the course of the 12 
hour experiment and data is represented box and whiskers plots, which extend from 
the 25th to 75th percentiles with a line at the median and error bars to the minimum 
and maximum values. A Kruskal-Wallis non-parametric test with Dunn’s multiple 
comparisons post-test was used. Both microgel containing groups had average 
migration speeds statistically significantly greater than the fibrin along group 
(p<0.0001) and the 10 U/mL thrombin sample was significantly less than the 1.0 
U/mL thrombin (*p<0.05). 
 
 When cell motility was analyzed in these composite systems with different 
architectures, cells in the ULC microgel groups polymerized with 1.0 U/mL thrombin 
displayed significantly higher average migration speeds compared to cells polymerized in 
10 U/mL thrombin, with average speeds of 15.82 µm/hr and 9.09 µm/hr respectively. 
Thus, these results suggest that microgel network average radius may be an important 
factor in enabling enhanced cell motility in these hybrid fibrin-microgel constructs.  
5.3.3 Depletion induced pre-clustering of microgels in alginate solutions 
The route towards generating these hybrid materials is not limited to exploiting 
the polymerization dynamics of fibrin. Similar materials were generated by inducing 
microgel-cluster formation via depletion interactions, i.e. attractive forces between 
microgels due to osmotic pressure induced by local depletants [253], specifically in 
alginate (Figure 23). A solution of the anionic polysaccharide alginate was mixed with a 
ϕ=0.112 ULC microgel solution, and prior to gelation (Figure 23 C-E), effects of 
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depletion were observed, i.e. clustering of microgels induced from local alginate 
polysaccharide chains. Alginate concentration was decreased incrementally (from 1% to 
0.5%) and at significantly low concentrations (0.1%, Figure 23F), depletion was no 
longer observed — microgels remained homogenously dispersed.  
 
 
Figure 23: Clustering of microgels within alginate-microgel hybrid constructs.   
Confocal slices of composite gels with ULC microgels (ϕ=0.112), scale bar 20 µm. A) 
Ca2+ crosslinked alginate with ULC microgels. B)  ULC microgels (ϕ=0.112) in 
buffer prior to the adition of alginate. C) Pre-clustering of ULC microgels (ϕ=0.112) 
with 1% alginate added to the solution. D) Pre-clustering of ULC microgels 
(ϕ=0.112) with 0.5% alginate added to the solution. E) Time-evolved pre-clustering 
of ULC microgels (ϕ=0.112) with 0.5% alginate added to the solution after 15 
minutes. F) ULC microgels (ϕ=0.112) with 0.1% alginate added to the solution. 
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Thus, when microgels were mixed with high molecular weight alginate solutions, 
pre-clusters of microgels formed that could later be immobilized upon initiation ionic 
crosslinking of the network with the addition of Ca2+ (Crosslinked gel shown in Figure  
23A). Additionally, clusters of microgels were observed to grow over time (Figure 23E), 
thus these structures could be tuned through changing the time at which the network is 
crosslinked with the addition of divalent cations.  
5.3.4 PEG-microgel composite materials and interactions 
 Results from the confocal image slices and stacks of hybrid PEGDA and PEG-
4MAL gels (4% PEG final weight percent) with ULC microgels (ϕ=0.112) displayed in 
Figure 24 demonstrate no microgel clustering.  
 
 
Figure 24: Imaging of microgels within crosslinked PEG-microgel hybrid 
constructs.   Confocal slices of composite gels with ULC microgels (ϕ=0.112), scale 
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bar 20 µm. A) PEG-4MAL GDQ crosslinked gels formed with CLP in pH 3 HEPES 
buffer. B)  PEG-4MAL GDQ crosslinked gels formed with CLP in pH 5 HEPES 
buffer. C) PEG-4MAL GDQ crosslinked gels formed with CLP in pH 7.4 HEPES 
buffer.  D) PEGDA gel with microgels formed via UV free radical polymerization 
initiated by Igracure 2959 exposed to UV for 10 minutes. E) Fibrin 8 mg/mL gel 
with clustered microgels, for comparison. 
 Microgels remain homogenously dispersed throughout the gel solution throughout 
the duration of the experiment (both prior to gelation and after addition of the 
crosslinking peptide). As it was expected that the presence of PEG may induce a 
depletion attraction, the experiment was repeated without the addition of the cross-linking 
peptide and microgels were mixed with PEG and imaged (Figure 25). 
 
Figure 25: Imaging of microgels within PEG-microgel hybrid suspensions.   
Confocal slices of solutions of ULC microgels (ϕ=0.112) A) in buffer or B) in a 6% 
solution of PEG-MAL, scale bar 20 µm. Images (videos) were acquired after the 
solutions had been allowed to sit and equilibrate for 1 hour. 
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 After the samples had equilibrated for an hour, there were still no indications of 
depletion in the group that contained 6% PEG-4MAL added to the solution. However, 
when time-lapse images were acquired of the sample, compared to the microgels only in 
buffer, it was apparent that the PEG was in fact slowing diffusion/Brownian motion of 
the particles.  
5.4 Discussion 
This work demonstrated microgel network formation in fibrin is governed by 
fibrin polymerization rate. If polymerization is fast, the microgels do not have time to 
rearrange and the resultant average radius of the structures is small, while if slow, the 
microgels can gradually be driven together forming larger structures. As a result, the 
mechanism of microgel domain assembly is governed by the polymerization dynamics of 
fibrin and allows for tunability of network architecture for a given application. When cell 
motility was analyzed in these composite systems with different architectures (but 
identical fibrin and microgel concentration), there were no significant differences in 
migration speed. However, due to the slow polymerization rate of the 0.1 U/mL thrombin 
hybrid gels, cells would settle to the gel-culture dish interface and thus these materials 
could not be analyzed. It was found that fibrin 8 mg/mL gels with ULC microgels 
(ϕ=0.112) polymerized with 1.0 U/mL thrombin displayed significantly greater average 
migration speeds compared to a 10 U/mL thrombin sample. This is likely because the 
microgel networks formed at higher thrombin concentrations have smaller network 
diameters (3.47 µm compared to 4.5 µm) and thus require more matrix degradation prior 
to cell motility.  
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 While alginate was able to support the formation of microgel networks, the 
attempts to form them within PEG failed. For undetermined reasons, it appears that 
depletion does not occur in the PEG system, yet one may expect this to occur based on 
the physical principles of the phenomena. However, PEG is a relatively uncharged 
molecule while alginate is highly anionic. Perhaps there is additional swelling of alginate 
in salt solutions compared to PEG where the effective volume fraction of alginate is in 
the end, much larger than for the PEG. When simply mixing PEG-4MAL and microgels, 
it was observed however that the diffusion and thermal fluctuations of ULC microgels 
(ϕ=0.112) in buffer solutions was greater than in solutions with increasing concentrations 
of PEG-4MAL. Thus, PEG may hinder diffusion and serve as a molecular crowder, yet 
the osmotic pressure is not quite high enough to drive the formation of clustered microgel 
domains. 
 Overall, these results demonstrate the ability of microgel networks to form in 
other materials, such as alginate. Thus one could view these findings to suggest a 
paradigm shift in the way that composite ECM mimetic materials are designed. In the 
future of this project, more work could be done to test other ECM mimicking 
biomaterials that may allow for interconnected microgel network formation. However, in 
order to recapitulate the native ECM using synthetic engineering strategies, colloids 




CHAPTER 6  DETERMINE THE POTENTIAL OF HYBRID 
FIBRIN-MICROGEL CONSTRUCTS TO ENHANCE CELL 
INFILTRATION USING IN VIVO SYSTEMS 
6.1 Introduction 
 To demonstrate in vivo feasibility of this composite gel tissue engineering 
strategy, the hybrid constructs were tested using a subcutaneous implant model. This 
animal model is utilized as an initial test of a material for biocompatibility and 
vascularization. While it may not be wholly applicable for deducing information to apply 
to a specific disease state, it is a simple surgery that provides a general outlook on the 
ability of the material to integrate with the host tissue and can also serve to identify the 
potential problems with the foreign body reaction [109]. Many others have utilized 
subcutaneous implants to assess vascularization in engineered materials [223, 254-256]. 
However, for concerns that growth factor mediated angiogenic cues would overwhelm 
the potential differences, and knowing that fibrin degradation products are pro-
angiogenic, fibrin alone and fibrin-microgel constructs were tested in this model. The 
hypothesis for this aim was that the presence of microgels would enhance angiogenesis 
and vascularization due to the ability of microgels to enhance migration. After four 
weeks, to quantify vascularization of the implant, micro-CT and lectin perfusions were 
performed in order to label vasculature within the embedded tissues. Cell infiltration was 
also quantified through histological staining and imaging. 
 Additionally, to better understand the in vivo results, in vitro angiogenesis assays 
were investigated. First, an ex vivo microvessel fragment angiogenesis assay was 
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performed, which has been utilized previously for the testing of engineered fibrin 
matrices [7]. In vitro sprouting and neovessel formation of primary multicellular vessel 
fragments has been extensively studied [7, 211-217, 257-259]. Upon primary isolation 
and digestion from the tissue, these fragments comprised of endothelial cells, pericytes, 
and red blood cells have been shown to growth and form interconnected tubule networks, 
which can then anastomose with host vasculature when implanted in vivo. Thus, this 
assay represents a more complex angiogenesis model system to study these processes.  
 To investigate the process of angiogenesis at an even more simplified level, 
human umbilical vein endothelial cells were cultured on collagen coated microbeads 
[260] embedded within the fibrin-microgel hybrid constructs to observe sprouting of 
single cell type structures. Through the collection of these experiments, the angiogenic 
potential of these hybrid constructs was measured and quantified. 
6.2 Materials and methods 
6.2.1 Rat subcutaneous implant model 
6.2.1.1 Electrospinning PCL nanofiber mesh scaffolds 
 In order to create the poly(caprolactone) (PCL) nanofiber meshes, 12% w/v PCL 
was dissolved in a 90:10 mixture of HFP:DMF (1,1,1,3,3,3-Hexafluoro-2-propanol : N,N-
Dimethylformamide). After overnight dissolution, 5 mL of the solution was loaded into a 
10mL syringe and placed on a syringe pump facing the copper collecting surface 
connected to a voltage supply. The positive wire from the voltage supply was wrapped 
around the needle on the end of the syringe containing the polymer solution. Polymer was 
infused at 0.75 mL/hr and the voltage source was turned on (10-15 kV) after a few 
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minutes to ensure initial polymer flow out of the syringe and stable Taylor cone 
formation. Electrospun polymer was generated on aluminum sheets taped to the copper 
coated collecting surface over the course of five hours. Sheets of electrospun polymer 
were then laser cut into rectangular meshes with 1 mm diameter cut out holes. 
Rectangular meshes are then formed into 12 mm x 5 mm diameter cylinders using UV 
curable glue. Meshes were sterilized in 100% absolute ethanol overnight and stored in 
PBS until use. 
6.2.1.2 Pre-forming polymerized fibrin gels in scaffolds 
 Fibrin gels of the various groups (8 mg/mL fibrin, 8 mg/mL fibrin + ULC 
microgels ϕ=0.112, 25 mg/mL fibrin, 25 mg/mL fibrin + ULC microgels ϕ=0.112, and 
2.5 mg/mL fibrin) were formed as previously described, but filled within the PCL 
nanofiber meshes that were placed in 96 well plates. After 1 hour of polymerization, 
constructs were then removed and surgically implanted into the rats. Containment of the 
hydrogels within the PCL tubes allowed for convenient determination of scaffold location 
at the end of the study. For the lectin perfusion groups, the microgel containing constructs 
contained ϕ=0.112 of AF647 ULC microgels. 
6.2.1.3 Implantation surgical procedure 
 In order to test vascularization potential of the composite gels, male Sprague 
Dawley rats (n=8-10 Micro-Fil perfusion, n=3 lectin perfusion) approximately 8 weeks of 
age underwent a subcutaneous implant procedure (Harlan, Tampa, FL). Two 2 cm 
incisions were made on the dorsal side of the rat, and two pockets in the subcutaneous 
space were made lateral to the incision sites by blunt dissection. The constructs were 
inserted into the subcutaneous pockets away from the incision site, and incisions were 
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closed with sutures and wound clips. Aseptic procedures were followed throughout the 
surgery, and the Georgia Institute of Technology Institute Animal Care and Use 
Committee approved all procedures.  
6.2.1.4 Perfusion and tissue harvesting 
 After four weeks, the vasculature was cleared with 0.9% saline containing 0.4% 
papaverine hydrochloride (Sigma-Aldrich), perfusion fixed with 10% neutral buffered 
formalin, rinsed again with 0.9% saline. For the Micro-Fil perfusion (n=8-10 per group), 
15-25 mL of lead chromate-based radiopaque contrast agent (Microfil MV-122, 
FlowTech) prepared according to manufacturer’s instructions with a 2:1 dilution of 
contrast agent with diluent was injected with a syringe [261, 262]. Samples were stored at 
4° C overnight for polymerization of the contrast agent after which constructs were 
excised from the animal and fixed for three hours in 10% formalin. Constructs were then 
transferred into 30% sucrose solutions in PBS for two days and stored at 4° C. Next 
samples were OCT vacuum-embedded for one hour periods in various ratios of 30% 
sucrose to OCT (1:0, 4:1, 3:1, 2:1, 1:1, 1:2, 0:1). Once the sample was in 100% OCT it 
was left to vacuum-embed overnight and then was moved into the -80° C freezer for 
storage. 
 For the lectin perfusion, the animals (n=3 per group excluding 2.5 mg/mL fibrin) 
were injected with either 10mL lectin dye at 0.1 mg/mL (DyLight 488 Lycopersicon 
Escuentum (Tomato) Lectin, Vector Laboratories), which incubated in the vasculature for 
10 minutes to allow for adequate staining. Post-perfusion, explants were harvested and 
fixed in 10% neutral buffered formalin overnight, switched into PBS, and sectioned for 
imaging.  
 101 
6.2.2 Micro-CT angiography 
 Tissue explants were placed into a sample holder within the Micro-CT 40 (Scanco 
Medical) machine and imaged in batch scans with medium resolution (12 micron voxel 
size (isotropic/cube elements), X-ray source and detector: energy = 55 kVp, intensity = 
145 µA, 250 ms integration time, pixel matrix 1024x1024). Scans were contoured and 
evaluated with a sigma of 1.2 and a Gaussian blur of 1.0 at a threshold value set at 85 for 
all of the samples (which was found to most accurately capture vessels without 
artificially enlarging them). Data was acquired and analyzed in a blinded fashion. 
Evaluations of the 3D vessel structure were performed in three different ways: contouring 
the volume and analyzing the entire construct, contouring the volume and analyzing the 
middle portion of the construct by cutting 25% off the each end of the cylinder (thus 
eliminating potential variability in the vascularization of the ends of the constructs), and 
contouring the volume but shrinking the contour radially by 10% (thus eliminating 
variability in whether or not the contours potentially contain tissue on the outside of the 
PCL mesh). 
6.2.3 Cell infiltration histological analysis 
6.2.3.1 H&E staining of frozen tissue sections 
 Tissue explants were frozen in OCT in blocks that were then cut into 7 µm 
sections on the CryoStar cryostat. OCT did not adequately infiltrate the constructs, 
especially the high fibrin concentration groups, thus some sections were cut onto cryostat 
sectioning tape. These tape sections were then stained rinsed with water, and stained with 
hematoxylin and eosin, cleared with 100% absolute ethanol, and mounted to plastic slides 
still in contact with the tape using a UV curable mounting media.  
 102 
6.2.3.2 Quantification of cell infiltration distance in subcutaneous implants 
 Images of H&E stained slides were imaged on a Nikon E600 light microscope 
(Nikon; Tokyo, Japan) using the 2X or 4X objective and color camera. For quantitative 
measurements, entire longitudinal cross sections of the tissue were imaged with a 10X 
(Plan-Apochromat NA 0.25) objective for magnification with a Nikon TiE microscope 
(Nikon; Tokyo, Japan) and CoolSNAP HQ2 monochromatic CCD camera (Photometrics; 
Tucson, AZ) with an automated stage to perform tile scanning at stitching of 10X images 
to form a larger composite image. Cell infiltration distance was quantified in a blinded 
fashion for each image from 3 locations on both the ends of the construct (top and bottom 
of the cylinder) and both of the sides (cell infiltrate through the pores/holes in the PCL 
mesh). Distances were averaged per construct and 3-4 slices (from different implants) 
were pooled.   
6.2.4 Analysis of lectin perfusion of smaller diameter vessels  
 The 12 mm explanted tissue was sectioned into 6 cross-sections each 2 mm thick. 
Cross-sections were placed on glass coverslips and volumes of the whole tissue area were 
tile scanned. Using a LSM 700 series fluorescent confocal microscope (Carl Zeiss 
Microscopy Ltd) with a 10X objective (EC Plan-Neofluar NA 0.3), image stacks (200um) 
were acquired 2 mm from each end of the PCL mesh/gel border. Images are represented 
as maximum intensity projections from the same regions within the gels for each 
condition. Dotted lines represent the region within the interior of the PCL nanofiber mesh 
and squares illustrate the region of interest that is magnified. 
6.2.5 Microvessel fragment angiogenesis assay 
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6.2.5.1 Microvessel fragment isolation and culture 
Epididymal adipose tissue of male Sprague Dawley rats was collected under 
anesthesia and processed by mincing, followed by limited digestion with collagenase 
(Worthington Biochemicals, Lakewood, NJ), and sequential filtration through a 500 µm 
and a 70 µm mesh to remove large tissue debris and smaller fragments and single cells, as 
previously described in the literature [7, 211-217, 257-259]. MVFs were suspended at a 
concentration of 20,000 fragments/mL, in the fibrinogen solutions (+/- ULC microgels), 
and immediately mixed with appropriate volumes of thrombin, cast into a 3D gel, and 
polymerized for 1 hour prior to addition of MVF media. Microvessel fragments were 
cultured in 50% DMEM and 50% F10 media supplemented with VEGF, PDGF, 
micronutrients, and penicillin-streptomycin. Media was changed the day after gel 
formation, and every other day subsequently. After 10 days in culture, samples were be 
fixed in 4% formaldehyde, permeabilized with 0.2% Triton X-100, blocked in 5% non-fat 
milk in PBS with 1% BSA, and stained with FITC-GSL-1 (Vector Laboratories) for 
cellular visualization. Neovessel sprouts from the parent fragments begin to appear by the 
4th day in culture and gradually form an interconnected network at low fibrin 
concentrations by day 10 [7, 212, 213].  
6.2.5.2 Quantifying microvessel sprouting and network formation in composite gels 
 Confocal 10X tile scans (2560x2560 µm) of 100 µm thick maximum intensity 
projections of GSL1 stained microvessel networks cultures were obtained and imported 
into MATLAB. The network analysis software from Chapter 3 was used to analyze 
various parameters of the 3D networks including total vessel volume, vessel length, and 
number of branches. 
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6.2.6 HUVEC sprouting and network formation  
6.2.6.1 GFP-HUVEC culture 
 GFP-HUVECs lentivirally transduced with the CytoLight green plasmid 
controlled under the CMV promoter were obtained from Essen Bioscience at passage 2. 
Cells were grown and expanded to passage 5 in EGM-2 media (Clonetics, Lonza). 
6.2.6.2 hMSC culture and Human Foreskin Fibroblast (HFF) 
 Prior to experimentation, Human MSCs (Lonza) were cultured up to passage 6 in 
DMEM with L-glutamine, sodium pyruvate, 1.0 g/L glucose, 10% FBS, and 1% 
penicillin-streptomycin. HFF’s were cultured in DMEM with L-glutamine, sodium 
pyruvate, 4.5 g/L glucose, 10% FBS, and 1% penicillin-streptomycin. Upon initiation of 
the sprouting assay, all cells were cultured in EGM-2.  
6.2.7 HUVEC coated bead angiogenesis assay 
 In this assay, endothelial cells were coated onto microbeads and embedded into a 
fibrin matrix to measure cell sprouting and growth away from the bead surface [260, 263-
266]. Cytodex-3 collagen coated microbeads (GE Life Sciences) were resuspended at 
0.5g per 50mL in PBS for three hours. Beads were then allowed to settle, rinsed in PBS 
three times, and autoclaved for sterilization. GFP-HUVECs were incubated with 
Cytodex-3 beads for 4 hours (shaking every 20 minutes) in EGM-2 at a concentration of 
1 million cells per 2500 beads (which can be counted under a microscope in a 10ul 
aliquot to determine concentration) in a flow cytometry round bottom tube at 37°C. After 
coating, beads were transferred into a T-flask with additional media and left overnight in 
the incubator. The following day, beads were suspended into fibrin gels with and without 
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microgels at a concentration of approximately 400 beads/mL of gel solution. 25,000 
hMSCs/mL of gel were also incorporated into the polymerizing constructs. Gels were 
polymerized for 20 minutes and HFF’s were plated on top of the gels in EGM-2 media at 
8,000 cells/mL of gel solution. After 7 days in culture, samples were fixed in 4% 
formaldehyde for 20 minutes, stored in PBS and imaged with the LSM 700 confocal 
microscope (with either 10X EC Plan-Neofluar NA/0.3 or 20X Plan Apochromat NA/0.8 
M27). 
6.2.8 Statistical Analysis 
 All statistical analyses were performed in GraphPad Prism (GraphPad Software, 
San Diego, CA). All alpha values were set to 0.05. For samples that did not pass a 
normality test, data is represented in box and whisker plots, which extends from the 25th 
to 75th percentiles with a line at the median and error bars to the minimum and maximum 
values. For micro-CT angiography vascular volume and volume fraction (which were 
non-normal distributions), a Kruskal-Wallis non-parametric test with Dunn’s post-test 
was performed, *p<0.05, **p<0.01. For total volume micro-CT analysis, data fit a 
normal distribution; therefore the data was analyzed using an ordinary one-way ANOVA 
with Tukey’s multiple comparisons test. For cell infiltration, a Kruskal-Wallis non-
parametric test with Dunn’s post-test was performed. For microvessel sprouting network 
analysis, a Kruskal-Wallis non-parametric test with Dunn’s post-test was performed, 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
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6.3 Results 
6.3.1 Micro-CT angiography  
 All methods of quantification of the micro-CT evaluations resulted in similar 
trends show in Figure 26, where results from the full construct are in panel A, middle half 
are in panel B, and 10% radial reduction are in panel C. Quantitative outputs including 
vascular volume, total volume, and vascular volume fraction were obtained. Because the 
constructs likely change shape while in vivo (due to degradation or mechanical insult 
from the rats skin), the main parameter of interest is vascular volume fraction, which 
accounts for slight differences in construct volume. However, no significant differences 
were found in vascular volume fraction or vascular volume between any of the groups 
except with the 2.5 mg/mL fibrin physiological control, which had increased 
vascularization compared with the other groups. There were no significant differences in 




Figure 26: Micro-CT angiography of 4 week in vivo vascularization of hybrid fibrin-
microgel constructs.  A) Quantification of volume fraction, vascular volume, and 
total volume from the analysis of the entire contoured construct. B) Quantification 
of volume fraction, vascular volume, and total volume from the analysis of the 
middle section (25% off of each end lengthwise removed) of the contoured 



























































































































































































































































































































































































































































































































































































































total volume (TV) from the analysis of the entire length of the construct with the 
contour diameter reduced by 10% radially. Box and whiskers plot extends from the 
25th to 75th percentiles with a line at the median and error bars to the minimum 
and maximum values, n=7-10 independent gels from separate animals; For VV & 
VF, Kruskal-Wallis non-parametric test with Dunn’s post-test was performed, 
*p<0.05, **p<0.01. For TV analysis, data fit a normal distribution, but no 
significant differences were detected using an ordinary one-way ANOVA with 
Tukey’s multiple comparisons test. 
 
 Representative angiograms from each group can be seen in Figure 27 below. 
Qualitatively, no striking differences were observed between the 8 mg/mL fibrin groups 
and little vascularization was observed in the 25 mg/mL fibrin groups with and without 
microgels. Physiological concentrations of fibrin (2.5 mg/mL) displayed robust 







Figure 27: Representative micro-CT angiograms of 4 week in vivo vascularization of 
hybrid fibrin-microgel constructs. Fibrin only 2.5 mg/mL. B) Fibrin only 8 mg/mL.  
C) Fibrin 8 mg/mL + ULC microgels (ϕ=0.112). D) Fibrin only 25 mg/mL. E) Fibrin 
25 mg/mL + ULC microgels (ϕ=0.112). 
 
 When examining angiograms from different animals that were placed at different 
anatomical locations, a large amount of variability is present within the data. This can be 
appreciated in Figure 28, which shows 4 different implants from the fibrin 8 mg/mL 
group with ULC microgels ϕ=0.112. In general, upper constructs tended to display more 
vascularization compared to constructs implanted on the lower portion of the rat.  
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Figure 28: Representative micro-CT angiograms of 4 week in vivo vascularization of 
fibrin 8 mg/mL + ULC microgels (ϕ=0.112) in different anatomical locations. The 
variability in A) upper left implanted construct B) upper right implanted construct 
C) lower left implanted construct and D) lower right implanted construct 
demonstrate the diversity in the vascularization response of these anatomical 
locations. 
 
6.3.2 Histological quantification of rat subcutaneous implant model 
 Representative images of H&E stained sections can be seen in Figure 29. Yellow 
dotted lines represent the middle of the construct, black dotted lines represent the cell 
infiltration border, ‘P’ represents regions where the PCL nanofiber mesh is present, and 
‘F’ represents region where residual fibrin gel is remaining. Fibrin 8 mg/mL groups with 
and without microgels displayed more robust cell infiltration compared to both 25 mg/mL 




Figure 29: Representative H&E histological sections of 4 week in vivo 
vascularization of hybrid fibrin-microgel constructs.  2X images of tissue sections 
were acquired of A) Fibrin 8 mg/mL B) Fibrin 8 mg/mL + ULC microgels ϕ=0.112 
C) Fibrin 25 mg/mL D) Fibrin 25 mg/mL + ULC microgels ϕ=0.112. Yellow dotted 
lines represent the middle of the construct, black dotted lines represent the cell 
infiltration border, ‘P’ represents regions where the PCL nanofiber mesh is present, 
and ‘F’ represents region where residual fibrin gel is remaining.  
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 From H&E stained sections, cell infiltration distance was measured and results are 
shown in Figure 30. No significant differences in infiltration distance were found in any 
of the groups, from either the ends of the cylindrical constructs or through the holes in the 
PCL mesh on the sides. Most of the 2.5 mg/mL control samples had complete bridging of 
the infiltrating cells across the entire implant and thus were not included in this analysis 
(data not shown). 
 
 
Figure 30: Cell infiltration quantiation from H&E histological sections of 4 week in 
vivo vascularization of hybrid fibrin-microgel constructs.  Tiled 10X images of tissue 
sections were acquired from Fibrin 8 mg/mL, Fibrin 8 mg/mL + ULC microgels 
ϕ=0.112, Fibrin 25 mg/mL, Fibrin 25 mg/mL + ULC microgels ϕ=0.112, and Fibrin 
2.5 mg/mL. Infiltration distance (µm) was quantified from 3 locations on either side 
of the construct from A) the sides of the construct (which contained the laser cut 
holes in the PCL nanofiber mesh, or B) the ends of the cylinder, which contained a 






















































































































extends from the 25th to 75th percentiles with a line at the median and error bars to 
the minimum and maximum values, n= 3-7; Kruskal-Wallis non parametric test 
with Dunn’s post-test show no significant differences between any of the groups. 
 
6.3.3 Lectin vessel confocal imaging of explanted tissue from rat subcutaneous 
implant model 
 While the micro-CT data allows for robust quantitation of vessel volumes and 
other parameters, there are some limitations of the system including: 1) the voxel size is 
more ideal for larger diameter vessels, and 2) the viscosity of the contrast agent (Micro-
Fil) can inhibit infiltration of smaller diameter vessels. With these concerns in mind, a 
small molecule lectin dye was diluted in saline and perfused for visualization of smaller 
diameter vessels that had infiltrated the constructs. Maximum intensity projections of 200 
µm thick sections at each 2 mm section were acquired, and Figure 31 shows 
representative whole scans (n=3) from each group 2 mm within the construct. No 
qualitative differences in the lectin perfusion were observed in the 8 mg/mL fibrin 
constructs with or without microgels. However, little to no infiltrating blood vessels were 
observed in the 25 mg/mL fibrin groups whereas many small vessels were observed at the 
2 mm depth were observed in the 25 mg/mL construct containing microgels. These small 
vessels ranged from approximately 10-20 µm in diameter. Additionally, microgels were 
still found within the constructs after 4 weeks and vessels were seen to be growing in 
areas where microgels were present. Thus, the addition of ULC microgels into fibrin 
biomaterials made at supraphysiological concentrations enhanced the in growth of native 
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blood vessels within the biomaterial compared to minimal infiltration a observed in fibrin 
only control groups at 25 mg/mL. 
 
 
Figure 31: Maximum intensity projections of lectin perfused subcutaneous implants 
hybrid fibrin-microgel constructs at 4 weeks.  Tiled 10X images of 200 µm thick 
tissue sections were acquired from Fibrin 8 mg/mL, Fibrin 8 mg/mL + AF-647 ULC 
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microgels ϕ=0.112, Fibrin 25 mg/mL, Fibrin 25 mg/mL + AF-647 ULC microgels 
ϕ=0.112. (Scale bar 200 µm.) 
 
6.3.4 Microvessel fragment angiogenesis and sprouting quantification 
 Microvessel fragments were embedded in fibrin gels with and without microgels 
and a representative day 0 image of the GSL1 lectin stained fragments can be viewed 
below in Figure 32. Fragments are variable in size, but are multicellular capillary 
fragments that contain red blood cells, pericytes, and sometimes red blood cells. 
 
Figure 32: Microvessel fragment morphology on Day 0 immediately after 
encapsulation in hybrid fibrin-microgel constructs.  Tiled 10X images of 100 µm 
thickness were acquired from lectin stained MVF cultures embedded in Fibrin 8 
mg/mL, gel. Scale bar 1 mm on tiled image and 100 µm on zoom in portion. 
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 Robust microvessel networks were formed in the 2.5 mg/mL and 8 mg/mL fibrin, 
whereas the density of the fibrin at 25 mg/mL prohibited complete network sprouting and 
connectivity in the gels after 10 days in culture (Figure 33). A zoom in from Figure 33E 
is shown in panel F of Figure 33 where the multicellular nature, tube-like structure, and 
size of the microvessel fragment can be appreciated. 
 
 
Figure 33: Microvessel fragment sprouting over 10 days in hybrid fibrin-microgel 
constructs.  Tiled 10X images of 150 µm thickness were acquired from lectin stained 
MVF cultures embedded in A) Fibrin 8 mg/mL, B) Fibrin 8 mg/mL + ULC 
microgels ϕ=0.112, C) Fibrin 2.5 mg/mL, D) Fibrin 25 mg/mL, E) Fibrin 25 mg/mL 
+ ULC microgels ϕ=0.112, 500 µm scale, F) Zoom in on individual fragment next to 
arrow in E, 25 mg/mL + ULC microgels ϕ=0.112 sample, 20 µm scale.  
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 Large tile scans (2560 x 2560 µm) from at least four different gels were analyzed 
in MATLAB using similar methods as described in Chapter 3 for microgel network 
analysis and vessel arc length, total vessel volume, and number of branches. When 
quantified, the main differences that were observed were found between the different 




Figure 34: Quantification of microvessel fragment sprouting over 10 days in hybrid 
fibrin-microgel constructs (ULC microgels ϕ=0.112).  A) Quantification of total 
vessel volume for the various constructs (pooled data from n=4 samples) B) 
Quantification of total number of branches summed for each sample (n=4) for each 
group and C) vessel arc length. Box and whiskers plot extends from the 25th to 75th 
percentiles with a line at the median and error bars to the minimum and maximum 
values, n=4 independent gels (n=994-1398 vessels/branches analyzed in B); Kruskal-






























































































































































































 No differences in the ± microgel groups at the same fibrin concentration were 
observed in analysis of total vessel volume or number of branches. However, the non-
parametric analysis of vessel arc length demonstrated that there were significant 
differences in vessel arc length between fibrin 25 mg/mL and fibrin 25 mg/mL + ULC 
microgels ϕ=0.112 (*p<0.01). While the differences shown between the 8 mg/mL 
samples are inconclusive, and the total number of branches and total volumes of the 25 
mg/mL samples ± microgels are not significantly different, this data does present 
potential for microgels to enhance vessel arc length within this in vitro angiogenesis 
model. 
6.3.5 GFP-HUVEC coated bead sprouting/angiogenesis qualitative observations 
 HUVEC coated beads were imaged on the confocal microscope and no qualitative 
differences were observed between groups with and without ULC microgels after 7 days. 
While some sprouting was seen at 8 mg/mL fibrin with and without microgels, no 




Figure 35: Representative GFP-HUVEC sprouting from collagen coated beads after 
7 days in hybrid fibrin-microgel constructs. A) Fibrin 8 mg/mL, B) Fibrin 8 mg/mL 
+ ULC microgels ϕ=0.112, C) Fibrin 25 mg/mL, D) Fibrin 25 mg/mL + ULC 
microgels ϕ=0.112. E) Fibrin 2.5 mg/mL, scale bar 200 µm. 
 
 Additionally, there appeared to be differences in fibrin degradation surrounding 
the microbeads that was observable in the samples with labeled fibrinogen (8 mg/mL 
fibrin +/- microgels, n=1). Where in Figure 36A the fibrin only group shows little fibrin 
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degradation around the bead with small amounts of sprouting, panel B shows significant 
degradation and cell-mediated deformation of fibrin fibers distant from the bead and 
GFP-HUVEC surface. This will be examined in more detail within the discussion.  
 
 
Figure 36: Evidence of variable degradation in GFP-HUVEC sprouting from 
collagen coated beads after 7 days in hybrid fibrin-microgel constructs.  A) Fibrin 8 
mg/mL, B) Fibrin 8 mg/mL + ULC microgels ϕ=0.112, scale 50 µm. 
 
6.4 Discussion 
 The data acquired with micro-CT angiography illustrating the vascularization of 
the subcutaneous implants was inconclusive. In general, there appeared to be more 
vascularization at the ends of the PCL nanofiber meshes as opposed to in the center, with 
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little vascular bridging in any of the groups except for the physiological fibrin controls. 
This data thus suggests that the lowest fibrin concentration samples perform the best with 
respect to vascularization. This is not surprising as it is an excellent positive control for in 
growth into a porous matrix with quick turnover. Additionally, the literature supports 
these results with respect to fibrin gels at 2.5 mg/mL being capable of supporting 
sprouting in vitro. However, in reality these structures will not be maintained in vivo 
without the stability and structural support of the PCL mesh. Fibrin gels at physiological 
concentration will be degraded and resorbed quickly in vivo [9, 267, 268], but the 
stiffness and ability for the PCL mesh to hold its shape may have significantly altered the 
interpretation of these results. This is evident as there are no statistical differences in the 
total volumes of the tissue explants, whereas a hypothesis strongly supported by the 
literature would be that the physiological fibrin gels should have collapsed and fully 
degraded after 1 month in vivo [9, 88, 269-271]. For example, in the in vitro microvessel 
fragment assay, at the 10 day time point intact gel regions still persisted, but there was 
noticeable degradation of the 2.5 mg/mL fibrin only gels.  While the other fibrin gels may 
have received structural support from the PCL mesh as well, histological evidence of the 
25 mg/mL samples suggested the presence of fibrin within the center of the explants 
indicating that these gels had not fully degraded. Additionally, while not tested within 
this work, it is known that the mechanical and adhesive properties of physiological fibrin 
gels are not sufficient to stop major bleeds, seal large wounds, or facilitate stable 
anastomoses compared to fibrin sealants (thus initially rationalizing the generation of 
fibrin sealants with high fibrinogen concentrations to improve mechanics) [92]. 
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 Ultimately, results from the Micro-Fil micro-CT perfusions did not correlate with 
qualitative results obtained from the lectin perfusion. The hypothesis for these differences 
is that the micro-CT was unable to detect vessels with diameters smaller than 50 µm due 
to the higher viscosity of Micro-Fil, which is unable to flow through into these smaller 
vessels [272]. However, as the lectin dye is suspended in saline, smaller vessels and 
capillaries that have infiltrated the constructs can be visualized in the imaged tissue cross-
sections. 
 The presence of microgels on microvessel spouting in the in vitro model of 
angiogenesis primarily demonstrated effects between different fibrin concentrations. 
These results could have been a product of the matrix architecture not being conducive to 
the growth and migration of larger multicellular structures. One could also hypothesize 
that the adhesive environment within the microvessel may have been more desirable than 
the surrounding matrix architecture, causing there to be less of a driving force for 
proliferation and migration. However, vessel arc length demonstrated that there were 
significant differences in vessel arc length between fibrin 25 mg/mL and fibrin 25 mg/mL 
+ ULC microgels ϕ=0.112, suggesting potential for enhanced vessel growth with 
microgels incorporated into constructs at high fibrin concentrations. 
 The presence of microgels had no significant effects on the sprouting of HUVECs 
from collagen-coated beads. When analyzing gels that were polymerized with 
fluorescently labeled fibrinogen, striking observations were made with the cells 
interaction with the fibrin matrix surrounding the bead. Significant degradation and 
deformation of the matrix was observed in the groups containing microgels. It is known 
that porosity can affect polymer degradation as pores represent additional stress raisers 
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and increase the available surface area of the material to environmental factors that may 
cause degradation [36]. HUVECs appeared to have generated significant traction forces 
on the matrix as visualized in the strain of fibrin fibers and deformation of the microgel 
network architecture around the bead interface. 
 These results shed light into the fact that perhaps there is a baseline level of 
degradation that must occur in order to allow space for these cellular structures to 
generate traction and contractile forces to initiate migration. Even though microgel 
networks are present within the 3D matrix, perhaps in situations where cells are 
connected as a part of a larger multicellular structure, the microgel network diameter is 
still not large enough to enable spreading and the generation of contractility from the 
collective cell group to facilitate differences between groups with and without microgels. 
In a somewhat unrelated study, Khetan and co-workers sought to understand the 
differences in mesenchymal stem cell fate decisions based on matrix stiffness, 
degradation, and spreading/confinement [49]. They found that cells in confined spaces (in 
hydrogels that inhibited local matrix degradation) would differentiate down an 
adipogeneic lineage independent of matrix elasticity. When cells were able to degrade the 
matrix and had high spread areas and tractions, they differentiated towards and 
osteogenic lineage.  Interestingly, switching the permissive hydrogel (that allowed local 
matrix degradation) to a restrictive state through delayed additional matrix crosslinking 
or inhibition of tension-mediated signaling, caused the spread osteogenic cells to switch 
towards an adipogenic phenotype even with no changes in cellular morphology. This 
work illustrates a similar idea that perhaps the presence of microgels enable cells to 
become more contractile through enabling protrusions to reach out and bind fibrin at 
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more distant locations (additionally causing increased spreading). Alternatively, perhaps 
microgels enable increased local degradation of the matrix in proximity to the cell body, 
which further increases cell spreading, contractility, and initiation of cell migration. 
Additionally, it has also been shown that multiple proteolytic mechanisms including 
MMP dependent and serine protease dependent degradation enables endothelial cell 
sprouting angiogenesis [266]. 
 The results of this work allowed for a detailed understanding of how these 
composite materials perform in various tests of angiogenesis and vascularization and 
have provided much insight to inform future iterations of this system. 
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CHAPTER 7  CONCLUSIONS AND FUTURE DIRECTIONS  
 There remains a challenge in regenerative medicine to design engineered tissues 
that have optimal mechanical properties for the target site, allow for adequate host-
material interaction/integration, and enable stabilized vascularization to promote 
longevity of the construct. We have generated a novel technology to enable cell 
infiltration and motility in dense biomaterial systems, specifically fibrin. Compared to the 
state of the native provisional fibrin matrix, this increased density requirement arises 
from the need for mechanical strength to either glue tissues, halt bleeding/heal wounds, 
or tune the mechanical properties of the construct for a specific therapy. Microgel-laden 
engineered fibrin matrices maintain the robust mechanical properties of dense fibrin 
matrices and yet are capable of cell infiltration in vitro and in vivo contrary to fibrin only 
controls.  
 Through harnessing the polymerization dynamics of fibrin, we were able to tune 
the architecture of microgel assemblies to form interconnected networks, which allowed 
for enhanced cell spreading, motility, and infiltration. Further investigation of the 
formation of these microgel tunnels has shown that the process is dependent on the bulk 
polymer used in the biomaterial composite system. We additionally have demonstrated 
polymers such as alginate are able to generate similar microgel tunneling structures, yet 
through different mechanisms, specifically depletion. When microgels are mixed with 
high molecular weight alginate solutions, pre-clusters of microgels form that then can be 
immobilized upon initiation ionic crosslinking. Thus, this technology is not limited to 
fibrin, but is applicable in other systems as long as pre-clustering or polymerization 
induced microgel clustering is observed.  
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 Others in the field have sought to augment biomaterials with or even generate 
tissue engineering constructs from colloidal assemblies. However, each of these 
approaches contains a fundamental challenge or limitation, which will be subsequently 
described. Hwang et al generated a composite fibrin gel doped with alginate 
microparticles for applications in soft tissue reconstruction where volume retention of the 
implant is necessary after traumatic injury or tumor resection [20]. While the 
polydisperse alginate beads (ranging from 50-500 µm) enabled the implant to maintain its 
structure compared to the fibrin only implant that was completely resorbed after 12 
weeks, the presence of the alginate beads significantly diminished the compression 
modulus of the composite material. Additionally, alginate beads did not enhance initial 
cell spreading or infiltration into the dense fibrin composites. 
 Another colloid based tissue engineering strategy was recently reported by Griffin 
et al., describing microporous annealed particle (MAP) gels inspired by porogens [273]. 
PEG based microparticles were generated using a water-in-oil droplet segmentation 
microfluidic set up for the self-assembly of monodisperse microgels (crosslinked with 
Michael addition reaction) with diameters of 30 to 150 µm. Particles were then annealed 
together utilizing FXIII crosslinking to form shape-molding colloidal gels with a porosity 
arising from the spaces in between the microparticles. The constructs were able to 
promote accelerated wound closure rates in vivo compared to non-porous controls. 
However, microfluidic approaches for the generation of these monodisperse 
functionalized colloids suffer from low throughput (100 µl of microgels in 1 hour) while 
precipitation polymerization of pNIPAM microgels can result in liters of product within a 
few hours. 
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 A similar technology to MAP gels was reported in 2010 with the generation of 
‘modugels’ by Scott et al [274]. Here, differentially functionalized PEG-RGD microgels 
were centrifuged to form a compact colloidal gel around cells, which maintained initial 
viability in the constructs. However, the constructs were not tested in vivo, and several 
drawbacks relating to the difficulty of their fabrication for in situ shape-molding 
applications is immediately apparent. Finally, work from Buddy Ratner utilized sphere-
templated biomaterial implants with uniform interconnected pores [275]. While these 
implants displayed reduced fibrosis and increased vascularization, it is a fundamental 
porogen system, where extensive processing of the material with harsh solvents must be 
performed. 
 Our approach remains unique in that microgels form interconnected networks 
upon the dynamic assembly of fibrin and their structures can be tuned through 
adjustments in fibrin polymerization. High volume fractions of microgels are additionally 
used to structurally modify the base polymer system just upon simple mixing and 
addition of the catalytic enzyme thrombin. In systems where depletion could be expected 
to occur based on the size/molecular weight of the monomer and volume fraction, these 
clusters/ microgel networks can be formed even upon simple mixing (as in the example 
of alginate). The gel structure can then be subsequently frozen with the addition of a 
crosslinking solution containing a divalent cation. Additionally, the microgels did not 
affect the rheological properties of the fibrin composites, contrary to what is seen in most 
porogen/ porous systems [36]. Due to the unique softness of the pNIPAM-based 
microgels used in this work, cells are able to harness the interconnected microgel 
networks for enhanced cell spreading and motility. While significant enhancements in 
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vascularization among the groups remains to be fully realized, the fundamental 
groundwork characterizing the system in this project allows for future tuning of the 
system to succeed in different therapeutic areas. Additionally, many questions about the 
details of the system still remain, especially with respect to the cellular mechanism of 
action. 
 
Figure 37: Schematic of the potential of composite ECM-microgel colloidal 




 In the future, this work could be expanded upon in many ways to further 
understand the microenvironmental cues that exist in these composite matrices that 
influence cell infiltration and vascularization. As shown in Figure 37, while this work is 
immediately relevant to strategy 1, strategies 2-5 represent other directions that this work 
could follow in order to achieve other desired therapeutic outcomes. 
 From in vivo and in vitro investigations in aim 3, it was determined that 
potentially greater benefits could be realized from these materials if the diameters of the 
interconnected microgel networks could be increased.  This could potentially be achieved 
through the formation of composite networks using a newly realized microgel particle 
termed Giant ULC microgels (GULCs), which are 3-5 µm in diameter [180]. Once 
materials are generated with larger microgel network architectures, these materials could 
be tested in an animal model to assess vascularization.  
Testing within the subcutaneous implant model, could also be enhanced through 
providing the endogenous cells with a more prevalent angiogenic signal or cell 
recruitment cue, such as VEGF or SDF-1 [276]. VEGF is a native growth factor that is 
instrumental in angiogenesis in vivo and has demonstrated the ability to enhance 
vascularization in the subcutaneous model [223]. Stromal cell-derived factor-1α (SDF-
1α) is a well-studied CXCR4 receptor-related chemokine, known to be involved in 
hematopoietic stem cell activation, mobilization, and homing [277], and that has also 
been employed in various tissue engineering studies to recruit mesenchymal stem cells 
(MSCs) [278], endothelial progenitor cells (EPCs) [279], promote angiogenesis [280], 
and enhance wound healing [281]. Upon injury to tissues, stem cells are recruited from 
the bone marrow to home to the site of injury to aid in tissue repair [276, 282, 283].  
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SDF-1α has also been shown to induce VEGF secretion in endothelial cells [284, 285], a 
known pro-angiogenic factor, which will enhance recruitment and proliferation of 
endothelial cells and progenitors. Others have used local delivery of SDF-1α in controlled 
release hydrogel based systems for the recruitment of progenitor cells [286], but the 
hydrogels used do not display microstructures or pore sizes amenable for robust cell 
infiltration. 
In addition, previous work has demonstrated the ability to use pNIPAm-based 
microgels as tunable delivery vehicles for therapeutic molecules [174]. Based on the 
negative charge of the microgels, cationic proteins can be non-covalently encapsulated 
within the loose microgel particles. SDF-1α, like many chemokines, is positively charged 
and has also been administered to tissues via controlled release based on its charge [286, 
287]. This combinatorial approach would allow for not only a structural benefit to the 
matrix architecture, but also a therapeutic benefit through enhanced recruitment of 
progenitor cells to the implanted tissue. Before these studies are to be performed, it would 
be advised however that there may be some concern with loading these particles for 
controlled growth factor release. Due to the ultra low crosslinked nature of these 
particles, theoretically their internal polymer structure is a more open mesh compared to 
more highly crosslinked comparable pNIPAM-AAc. Thus, the growth factor may be 
more susceptible to burst release if diffusion out of the particle is less hindered. 
 Alternatively, in contrast to the study outlined in this dissertation, it may be 
beneficial to test the efficacy of the engineered material in an animal model where more 
vessels are present, such as the mesenteric fat pad [206, 207], or intramuscularly [9]. 
Comparatively to the subcutaneous space, these regions are more highly vascularized and 
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native tissue would have a higher incentive to infiltrate the constructs implanted within 
these regions. Although a convenient and straightforward test for an initial 
characterization of a new material, the subcutaneous implant model suffers from an 
overall lack of significant vascularization, animal-to-animal variability, and even 
variability based on anatomical location of the implant within the animal as found in 
these studies.  
 If larger microgel network structures are unable to be generated, this work still 
could have significant benefit in the field of cell delivery. Many therapeutic approaches 
of the future to heal wounded soft tissues or for the generation of organ structures will 
rely on the delivery of cells within complex biomaterial systems. Fibroblasts and other 
mesenchymal cells make up the dominant portion of the cell population within many soft 
tissues, and mesenchymal stem cells are one cell type of interest that is commonly 
investigated in tissue engineering. Mesenchymal cells, being adhesion-dependent, rely on 
cell-matrix interactions for survival and proliferation. When these cells are unable to 
spread, polarize, and migrate, their phenotype and survival is limited [288]. Studies 
investigating in vivo delivery of MSCs in animals have demonstrated large amounts of 
cell death upon implantation and proven difficulty in maintaining cell viability over the 
long term [251, 289-291]. Additionally, diffusion of nutrients and removal of waste 
products within dense matrices that inhibit spreading also becomes a challenge to 
overcome. Composite ECM-microgel materials could enable initial cell spreading and 
maintenance of natural phenotype in cell delivery systems where normally these 
processes are hindered or delayed. This could potentially lead to increased cell viability 
over the long term or enhance initial cell survival post-implantation. The delivery of 
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cardiac progenitor cells (CPCs) in hybrid fibrin-microgel matrices detailed in this 
dissertation is being tested currently in a model of myocardial infarction.  
 Overall, this work illustrates a new clinically relevant colloid-matrix assembly 
[171] that decouples stiffness and cell-viewed mesh size to enable cell infiltration and 




A.1. Supplemental experiments for insights into future directions  
A.1.1. Investigation of cell motility in microgel laden RGD-alginate gels  
A.1.1.1. Rationale 
 Alginate is popular biomaterial used in tissue engineering that is derived from 
seaweed [248]. Although it presents no native adhesion ligands for mammalian cells, it 
can be functionalized to present ligands such as RGD, in order to promote cell 
attachment, growth, and viability. Additionally, mammalian cells do not possess the 
enzyme (alginase) capable of degrading alginate [249]. Thus, it was hypothesized that 
adding microgels into RGD-alginate networks would enable cell spreading and migration 
contrary to RGD-alginate only constructs. 
A.1.1.2. Methods 
A.1.1.2.1. Cell seeded RGD-alginate gel formation and monitoring cell motility 
 RGD-Alginate was mixed with CMFDA-labeled NIH3T3 cells (methods 
previously described) with and without ULC microgels (ϕ=0.112) and cell culture media 
for a final cell concentration of 200,000 cells per mL in a 1% RGD-alginate gel. Calcium 
sulfate (final concentration of 6 mM) was added to the solution and mixed quickly before 
pipetting onto a tissue culture dish for subsequent gelation. Additional media was 
supplemented over top of the gels 30 minutes later and cells were left to grow and spread 
overnight. The next morning cells were subsequently monitored in the Nikon Biostation 
(imaged every 10 minutes for 12 hours). 
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A.1.1.3. Results 
 When cells were incubated in 1% RGD-alginate gels with and without ULC 
microgels, differences in cell morphology were found at the end of the experiment (~24 
hour time point). Cell migration (characterized as translocation of the cell body/nucleus) 
was only observed in a select few cells per region in the gels containing microgels, while 
no cells within RGD-alginate alone moved within these experiments. In the groups 
containing microgels, cells displayed robust protrusions compared to RGD-alginate only 
gels, but maintained a rounded morphology in general, only sprouting a few thin and long 
protrusions at a time. Examples of these morphologies can be seen below in Figure 38, 
where NIH3T3s in 1% RGD-alginate gels can be seen in panels A and B and are 
completely rounded. Microgel network formation is apparent from the granular quality of 
the phase contrast image in C, which shows cells in a 1% RGD-alginate gel with ULC 
microgels (ϕ=0.112). Additionally, protrusions can be seen (yellow arrows) in panel D, 
which shows the CMFDA labeled cells in the FITC channel. 
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Figure 38: Phase contrast and fluorescence images of NIH3T3s in RGD-alginate gels 
with and without microgels. Images from end of 12 hour experiment in the Nikon 
Biostation taken with a 10X objective, A) phase contrast of 1% RGD-alginate only 
gel, B) FITC image of CMFDA labeled NIH3T3s in 1% RGD-alginate only gel, C) 
phase contrast of 1% RGD-alginate gel with ULC microgels (ϕ=0.112), B) FITC 
image of CMFDA labeled NIH3T3s in 1% RGD-alginate gel with ULC microgels 
(ϕ=0.112). 
A.1.1.4. Discussion 
 Cells do not possess the adequate enzymes (alginases) to degrade alginate on their 
own, thus it degrades slowly over long time scales as ion exchange occurs. Therefore, 
these results are unique and demonstrate the potential for ULC microgels to enable cell 
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spreading (elongation of protrusions) and motility (observed qualitatively) within 
hydrogels that are not degradable by cellular mechanisms. Cell spreading and motility is 
visualized within the first 12 hours of incubation in the gels, thus the cells are leveraging 
the microgel networks through an unknown process. Future work could investigate this 
finding in more detail to better understand the mechanism. 
A.1.2. Formation of hybrid fibrin-microgel constructs with giant ultra low 
crosslinked microgels (GULCs) 
A.1.2.1. Rationale 
 The results from this dissertation suggest that to enable processes in which 
collective cell migration occurs, fibrin gels may require larger diameter microgel network 
tunnels to better support angiogenesis. Thus, one potential solution to this problem would 
be to use larger microgel, specifically giant ultra low crosslinked microgels (GULCs), 
which have diameters ranging from 3-5 µm [180]. In order to determine if larger 
microgels would create larger interconnected structures, confocal microscopy was 
performed on composite fibrin-GULC gels with fluorescently labeled fibrinogen. 
A.1.2.2. Methods 
A.1.2.2.1. GULC synthesis7 
 The synthesis of GULC microgels is similar to that of ULC microgels described 
in chapter 3 except that a temperature ramp is performed at the beginning of the reaction. 
Briefly, the reaction was initiated at 45 °C followed by an increase in temperature to 60 
°C at a rate of 30 °C/hr. After completion, the reaction solution was cooled to room 
temperature and filtered through glass wool. Microgels were centrifugally pelleted and 
redispersed in deionized H2O 3-6 times to purify and then lyophilized before use.   
                                                
7 Adapted from Bachman et al. Ultrasoft, highly deformable microgels, Soft Matter, 11 (2015) 2018-2028. 
Adapted from with permission by The Royal Society of Chemistry. 
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A.1.2.2.2. Hybrid gel formation and confocal microscopy 
 Gels were formed similarly as previously described in chapter 3, however, a final 
concentration of 4 mg/mL GULCs was utilized in the place of ULC microgels. 
A.1.2.3. Results 
 GULCs formed connected networks within dense fibrin gels as observed in Figure 
39 below. As GULCs average approximately 5 µm in diameter, outlines of individual 
particles can be viewed in the confocal image as thin fibrin fibers wrap around the 
periphery of the particles.  
 
Figure 39: Confocal image of fibrin gel 15 mg/mL with Giant ULC microgels (4 
mg/mL) incorporated during polymerization with 2 U/mL thrombin.Made with 
2.5% Alexa Fluor 647 fibrinogen, scale bar 20 µm. 
 Quantitative analysis of this image gives an average network radius of 4.05 µm 
compared to ULC microgels, which on average formed tunnels with a radius of 4.5 µm.  
 138 
A.1.2.4. Discussion 
 Although the data represented is only from a single independent experiment, the 
similar values in microgel network radius suggest that using larger microgels may not 
enable the formation of larger microgel network tunnels and as seen in the image, the 
GULCs seem to form more single microgel strings or lines of small clusters throughout 
the gel as opposed to large clusters. While the cluster size may be similar to cases where 
ULC microgels are used, ULC microgels have more particles per cluster, and thus 
potentially allow for cells to rearrange the grouping of microgels as opposed to a cell 
interrogating 1 larger microgel, which may be inhibitory to deformation/relaxation. 
However, microgel volume fraction is necessarily at ϕc in this experiment because 
viscometric experiments have not been performed on the GULCs. Thus, microgel 
concentration could be increased to ϕc for future experiments once it is determined and 
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